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Overview 
 
This thesis focuses on an adapted Mindfulness Based Cognitive Therapy 
(MBCT) group for depression in people with dementia (PWD) in memory clinics. 
Part I is a systematic literature review, including meta-analyses, examining 
the effectiveness of psychosocial interventions for depression and anxiety in people 
with dementia (PWD) or mild cognitive impairment (MCI), who are experiencing 
clinical symptoms of depression or anxiety. Seven randomised controlled trials 
(RCTs) are included in the review. 
Part II is a feasibility randomised controlled trial (RCT) that assessed 
whether an adapted MBCT group in memory clinics would lead to greater 
improvements in symptoms of depression, and anxiety, in PWD who were 
experiencing symptoms depression, as compared to treatment as usual. This is a 
joint project completed with Jacob Payne (JP). Measures of depression, anxiety, 
quality of life (QOL) and cognition were assessed at baseline and follow-up. JP 
reports on the feasibility of the intervention and measures of QOL and cognition. 
Measures of depression and anxiety are reported here. 
Part III is a critical appraisal, I will reflect on conducting the empirical study 
and my experience of facilitating a Mindfulness Based Cognitive Therapy (MBCT) 
group. Firstly, I will share how my background influenced my choice of research. 
Secondly, I will discuss the recruitment challenges and my experiences of 
facilitating the adapted MBCT group. Finally, I will consider the findings of the 
empirical paper, based on my experience of facilitating the group and the 
discussions I had with participants and carers.  
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Abstract 
Aims: To assess the effectiveness of psychosocial interventions for symptoms of 
depression and anxiety in people with dementia (PWD) or mild cognitive 
impairment (MCI), who are depressed or anxious.  
Methods: OvidMedline, PsycInfo and Embase were searched for studies, meeting 
the inclusion criteria, on the 17th October 2016. Cochrane Risk of Bias Tool rated 
the quality of studies. The efficacy of the studies was estimated using meta-analyses.  
Results: Seven randomised controlled trials (RCTs) were included. No RCTs were 
identified for people with MCI. Three RCTs found that psychosocial interventions 
(multicomponent intervention, Mahjong/Tai Chi and exercise/walking) were 
effective at reducing symptoms of depression in PWD who were depressed. One 
study (Mahjong/Tai Chi) found that these reductions were no longer evident at six 
month follow up. Another study, not included in the meta-analyses, found that 
pleasant events behaviour therapy and problem solving behaviour therapy were 
effective at improving depression symptoms at the end of treatment; and this effect 
remained significant at follow up. Three RCTs found that psychosocial interventions 
(music therapy and cognitive behavioural therapy (CBT)) were effective at reducing 
symptoms of anxiety in PWD who were anxious. Evidence from two of these RCTs 
(music therapy and CBT) showed that these improvements were evident at three to 
six month follow-up. 
Conclusions: The identified psychosocial interventions are effective at reducing 
symptoms of depression or anxiety in PWD experiencing these symptoms. This 
review is limited by the quality of studies, small sample sizes and the heterogeneity 
of the interventions, therefore high quality studies with larger sample sizes are 
required to test the efficacy of specific interventions such as CBT. 
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Introduction 
An increase in life expectancy has resulted in an aging population, with 
estimates suggesting that the proportion of older adults will rise from 10% to 20% 
by 2050 (UN Department of Economic and Social Affairs, 2013). Therefore, 
interventions for age-related health conditions, such as mild cognitive impairment 
(MCI) and dementia, are becoming a focus of clinical practice and research (Kaplan 
& Berkman, 2011). 
Mild Cognitive Impairment 
MCI is an intermediary phase of cognitive impairment that lies between 
typical aging and dementia (Petersen et al., 1999). Diagnostic criteria include: 
subjective changes in cognitive ability, objective impairment in at least one 
cognition domain (e.g. memory, executive function, attention, language or 
visuospatial skills), preserved functional abilities and no impairment in social 
functioning (Albert et al., 2011). The prevalence is estimated to be between 6% and 
12% for individuals aged over 60 (Sachdev et al., 2015), with the prevalence 
increasing with age (O’Bryant et al., 2013; Sachdev et al., 2015). There is an 
increased risk of people with MCI developing dementia, with between 15% and 
41% of cases developing a form of dementia every year (Gauthier et al., 2006; 
Geslani, Tierney, Herrmann, & Szalai, 2005). 
Dementia 
Dementia is characterised by the progressive decline in cognitive functioning 
(e.g. memory, executive function, attention, language or visuospatial skills) and 
activities of daily living (e.g. self-care, financial independence) (Albert et al., 2011; 
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WHO, 2016). It is estimated that between 5% and 7% of the global population has 
dementia (Prince et al., 2013). There are approximately 850,000 people with 
dementia (PWD) in the United Kingdom (UK) (Prince et al., 2014) and this number 
is expected to rise to 1,000,000 by 2021 (Heap, 2012).  
Depression and Anxiety 
Neuropsychiatric disorders, such as depression and anxiety, are common in 
PWD and MCI (Kane & Terry, 2015; Lyketsos et al., 2002; Monastero, 
Mangialasche, Camarda, Ercolani, & Camarda, 2009). The prevalence of depression 
is between 10% and 62% for PWD (Barca, Engedal, & Selbaek, 2010; Knapskog, 
Barca, & Engedal, 2011) and 16% and 25% for MCI (Feldman et al., 2004; Van Der 
Mussele et al., 2013). The prevalence of anxiety is between 5% and 21% in PWD 
(Ferretti, McCurry, Logsdon, Gibbons, & Teri, 2001; Starkstein, Jorge, Petracca, & 
Robinson, 2007) and between 10% and 45% in MCI (Forsell, Palmer, & Fratiglioni, 
2003). 
Depression and anxiety increase the risk of dementia in people with MCI 
(Cooper, Sommerlad, Lyketsos, & Livingston, 2015). They are also linked with 
poorer outcomes, such as reduced quality of life, worsened cognition, increased 
functional impairment, behavioural disturbance and mortality rates (Kales, Chen, 
Blow, Welsh, & Mellow, 2005; McCurry, Gibbons, Logsdon, & Teri, 2004; Rapp et 
al., 2011; Shin, Carter, Masterman, Fairbanks, & Cummings, 2005; Starkstein et al., 
2007). In addition to the health implications, the incidence of depression and anxiety 
in PWD and MCI are placing financial pressures on the National Health Service, 
with an increased demand on inpatient beds (Kunik et al., 2003). Therefore, 
evidenced based treatments for depression and anxiety are required for this 
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population. 
Psychotropic medication, such as antidepressants, are associated with 
adverse side effects (Stomski, Morrison, & Meyer, 2016); and their effectiveness for 
depression and/or anxiety in PWD and MCI are not demonstrated (Devanand et al., 
2003; Leong, 2014; Moretti, Torre, Antonello, & Pizzolato, 2006; Sepehry, Lee, 
Hsiung, Beattie, & Jacova, 2012). Therefore, depression and anxiety have been 
identified as a specific target for non-pharmacological interventions (Cooper et al., 
2015). 
Systematic Reviews 
A meta-analysis, consisting of three randomised controlled trials (RCTs), 
found that non-pharmacological therapies did not show a significant effect on 
depression scores in PWD (Olazarán et al., 2010). This could be the result of low 
baseline depression scores, or that the interventions were targeting cognition as 
opposed to depression. Nevertheless, evidence from two of these RCTs (Chapman, 
Weiner, Rackley, Hynan, & Zientz, 2004; Olazarán et al., 2004) found that group 
cognitive stimulation, combined with acetylcholinesterase inhibitors, was found to 
significantly improve symptoms of depression in PWD after one year of treatment, 
as compared to those treated with acetylcholinesterase inhibitors alone.  
In a systematic review, psychosocial interventions were found to improve 
depression in PWD, in seven out of the eleven studies reviewed (Teri, McKenzie, & 
LaFazia, 2005). A recent Cochrane review, including meta-analyses, found that 
psychological treatments reduced symptoms of depression and anxiety in PWD. 
However, there were no available RCTs including MCI (Orgeta, Qazi, Spector, & 
Orrell, 2014) and a large proportion of the studies included in this review did not 
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require the participants to meet criteria for anxiety or depression at baseline.  
A systematic review, consisting of seven RCTs and eight pre–post studies of 
psychological interventions, showed positive effects on depression scores in people 
with early dementia (Regan & Varanelli, 2013). This review also highlighted three 
RCTs and one pre-post study whose inclusion criteria stipulated that participants 
met criteria for depression at baseline; and these studies showed symptoms of 
depression improved for PWD that were experiencing depression. 
Aims of Review 
The current review extends previous reviews by completing a systematic 
review, with meta-analyses, to compare psychosocial interventions for PWD or MCI 
who meet clinical criteria for depression or anxiety at baseline.  
Methods 
Inclusion and Exclusion Criteria 
The PICOS framework (Petticrew & Roberts, 2006) was used to select studies. 
Inclusion criteria.   
Population: Participants that: (a) met criteria for dementia (including all types and 
stages), or (b) met criteria for MCI. They also met criteria for either depression or 
anxiety on a standardised outcome measure or a clinical interview on the baseline 
assessment, which was stipulated as an inclusion criterion in the study.  Participants 
could be recruited from any setting. 
Intervention: Psychosocial interventions that intended to reduce depression or 
anxiety. Psychosocial interventions were defined as interventions that focused on 
psychological or social factors (such as psychotherapy or an activity group), as 
opposed to a pharmacological intervention (Forsman, Schierenbeck, & Wahlbeck, 
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2011; Frederiksen, Farver-Vestergaard, Skovgard, Ingerslev, & Zachariae, 2015). 
Interventions could include caregivers or family members. Interventions for 
caregivers alone were not included. Interventions were included if they used a 
structured time-limited intervention between a participant and a facilitator, such as a 
weekly one-hour psychotherapy session that ran for eight weeks. The intervention 
could be delivered to individuals or groups. 
Comparator: The intervention would be compared to a control group; including 
treatment as usual (TAU), waitlist controls or a comparison intervention that could 
act as a control for the intervention under investigation. 
Outcomes: Studies were included if they reported at least one standardised measure 
of either depression (e.g. Cornell Scale for Depression in Dementia,) or anxiety (e.g. 
Rating of Anxiety in Dementia Scale). 
Study design: RCTs that collected outcome measures at baseline and post treatment. 
There was no restriction in the sample size used in studies.  
Publication characteristics: Published in peer-reviewed journals, in English at any 
time prior to the 17th October 2016.  
 Exclusion Criteria. 
• Quasi-experimental studies, case studies and qualitative research. 
• Pharmacological interventions. 
• Conference/poster presentations. 
• If more than one article presents the same data, only one article will be 
presented in the review. The original article was used in these instances. 
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Selection of Studies 
Relevant studies were identified using three search strategies. 
(1) A systematic search was conducted using bibliographic databases: Embase 
(1980-2016), OvidMEDLINE (1946 – 2016) and PsycINFO (1806 – 2016).  
The search terms were composed of three concepts: ‘cognitive impairments’, 
‘depression or anxiety’ and ‘psychosocial intervention’ (See Appendix A). 
Search strategies have been published for each database (Eady, Wilczynski, & 
Haynes, 2008; Higgins & Green, 2011; Wong, Wilczynski, & Haynes, 2006) 
and are used in Cochrane reviews. These were used in the search to facilitate 
the identification of studies using a randomised design. 
(2) Systematic reviews were identified during the systematic search; and they were 
checked for studies that met the inclusion criteria.  
(3) References in the identified studies were reviewed to find any further studies.  
Quality Rating of Studies 
Cochrane’s Risk of Bias tool, used to rate the quality of studies, was 
completed using Review Manager (Revman) Version 5.3. The studies were rated as 
low, unclear or high risk of bias in areas such as: selection bias, performance bias, 
outcome bias, detection bias, attrition bias, reporting bias and other sources of bias. 
Low risk of bias suggests that the biases were unlikely to have an impact on the 
study results. Unclear risk of bias infers that there was not adequate information 
provided to evaluate all potential biases; therefore, it could raise questions about the 
reliability of the study results. High risk of bias infers that biases may have reduced 
the confidence in the study’s results (Higgins & Green, 2011). The results are 
illustrated in the ‘Risk of Bias’ graph and ‘Risk of Bias’ summary. The risk of bias 
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informed the interpretation of the meta-analyses. 
Heterogeneity 
A statistical test (chi squared) measured the heterogeneity between the 
studies’ results (Deeks, Higgins, & Altman, 2008), with a low p-value indicating 
heterogeneity. The chi square test has been found to be poor at detecting true 
heterogeneity, especially when the meta-analysis includes a small number studies or 
when the overall sample size is small. A p value of less than 0.10 was used to 
determine if the studies were heterogeneous. However, heterogeneity is expected in 
meta-analyses due to variations in methodologies and clinical samples (Higgins, 
Thompson, Deeks, & Altman, 2003). Therefore, the heterogeneity was quantified 
using an I2 statistic. Approximate guidelines for interpreting heterogeneity suggest 
that heterogeneity around 25% is low, medium heterogeneity is around 50%, 
substantial heterogeneity is around 75% (Higgins, Thompson, Deeks, & Altman, 
2003).  
Data Synthesis 
Revman was used to complete the meta-analyses. A random-effects model 
was used to present the overall estimated effect on depression and anxiety. As the 
studies under investigation used a range of scales, the analyses used the standardised 
mean difference scores, as opposed to the mean difference. Effects were weighted 
by the inverse of the variance of the effect estimate. This gives more weight to 
studies with larger sample sizes because they have smaller standard errors. This 
reduces the imprecision of the pooled effect estimate. 
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Results 
A total of 2991 articles were extracted from the literature search, and the 
abstracts and titles of these articles were read. From these abstracts 48 were 
identified as possibly relevant to the search criteria. The full-length articles were 
checked against the inclusion and exclusion criteria. These were read in full and 
judged against the inclusion criteria. This resulted in seven articles selected for 
narrative synthesis and six of these were included in the meta-analyses (See Figure 
1). 
 
 
Figure 1: Study Flow Diagram 
		 18	
Excluded Studies  
Forty-one studies were excluded: five studies did not use a randomised 
design; 21 studies did not have inclusion criteria about participants meeting criteria 
for anxiety or depression at baseline; ten studies did not have inclusion criteria about 
participants meeting criteria for dementia or MCI; four studies were not testing a 
psychosocial intervention; one study did not use standardised measure of anxiety or 
depression; and one study assessed an intervention offered to carers. 
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Table 1: Summary of the studies’ demographic information, design features, outcomes and risk of bias. 
Study Design 
 
 
Treatment (N) and 
control (N) 
intervention 
Frequency/Duration 
Manual/ 
Integrity 
Checks. 
Intention to 
treat 
Population: inclusion criteria, 
research setting, mean age  
and gender 
Attrition Outcomes 
Measures for 
Depression and 
Anxiety 
Outcomes  
 
Study risk 
of bias 
Depression     
Bailey 
et al, 
2016 
RCT (2 arm); 
pre-post; no 
follow up 
 
 
 
Treatment (group 
intervention): Multi-
component intervention 
(26) 
Control: Treatment as 
Usual (25) 
Two 30 minute sessions a 
week for 6 weeks 
Manualised 
QAR-Depression 
Treatment 
Adherence 
checks within 
acceptable limits  
Intention to treat 
analysis used 
People with dementia (>60 
years) with mild to moderate 
cognitive impairment and 
symptoms of depression. 
Nursing home in USA. M = 
84.14 years (SD = 8.45)                                      
N = 55 (46 female, 9 male).                                                
8% Depression 
(CSDD, GDS)   
 
Reduction in 
depression compared 
to controls using the 
CSDD (p<.05) but not 
using GDS. 
High 
Cheng 
et al, 
2012 
Cluster RCT 
(3 arm); Pre-
post; 6 month 
follow up 
 
 
Treatment (group 
interventions): Mahjong 
and Tai Chi (24) Control: 
Handicrafts (12) 
One hour three times a 
week for 12 weeks 
Manual guides 
and integrity 
checks were not 
detailed. 
Intention to treat 
analysis was not 
used 
People with dementia with 
mild to moderate cognitive 
impairment (Clinical Dementia 
Rating score = 0.5 of 1) and 
symptoms of depression (GDS 
score ≥ 6). Nursing home in 
Hong Kong. M = 81.8 years 
(SD = 6.54). N = 37 (24 
female, 12 male).                                       
0% Depression 
(GDS)           
 
Reduction in 
depression in 
Mahjong and Tai 
Chi groups 
compared to controls 
(p< .006) at one 
week follow up. 
This was no longer 
significant at 6 
month follow up 
Unclear 
William
s & 
Tappen, 
2008 
RCT (3 arm); 
pre-post 
 
 
Treatment (individual 
intervention): Exercise 
and walking (30)   
Control: Conversation 
group (15) 
12 sessions 
 
The interventions 
were not 
manualised and 
there were no 
fidelity checks 
Intention to treat 
analysis was not 
used 
People with Alzheimer’s 
Disease with symptoms of 
depression (CSDD score ≥ 7). 
Nursing homes in USA.                                   
M = 87.9 years (SD = 5.95). N = 
45 (40 Female, 5 Male). 
20% Depression 
(CSDD, DMAS, 
AMS, OAS, 
MADRS) 
 
The depression 
group mean scores 
reduced on the 
CSDD, from 
baseline to follow-
up, in the treatment 
and control groups. 
 
High 
Teri et 
al, 1997 
RCT (4 arm); 
pre-post; 6 
month follow 
up 
Treatment (individual 
intervention): 1. 
Pleasant Events 
Behavior Therapy (23); 
2.Problem-solving 
behaviour therapy (15) 
Control: 1. Treatment as 
usual (10) and 2. waitlist 
control (20) 
Nine weekly 60-minute 
sessions 
The intervention 
was manualised 
No evidence of 
fidelity checks. 
Intention to treat 
analysis was not 
used 
People with probable 
Alzheimers and meet criteria 
for major or minor depressive 
disorder. Community research 
centre in the USA 
M = 76.4 (SD = 8.2) years. N 
= 72 (34 female and 38 male) 
25% 
 
 
 
 
Depression 
(HDRS, CSDD, 
BDI)                            
Reduction in 
depression scores in 
treatment groups as 
compared to controls 
on the HDRS 
(p<.001), CSDD 
(p<.001) and BDI 
(p<.01) at one week 
follow up. The 
significant effect 
was maintained on 
the HDRS (p<.001) 
and CSDD (p<.001) 
High 
Anxiety 
Guetin 
et al, 
2009 
RCT (2 arm); 
Pre-post; 6 
month follow 
up 
 
Treatment (individual 
intervention): 
Music Therapy (12) 
Control: Reading 
sessions (14) 
16 sessions, duration 
not reported 
 
There is some 
evidence that the 
music therapy 
was manualised, 
although it is not 
clear. 
Fidelity checks 
were not 
detailed. 
Intention to treat 
analysis was 
used 
People with Alzheimer’s 
Disease (70-95 years) with 
mild to moderate cognitive 
impairment (MMSE score 12-
25) and symptoms of Anxiety 
(HAS score ≥ 12); receiving a 
stable dose of anticholinergic 
treatment for 6 months. 
Nursing home in France. M = 
86.05 years (SD = 5.68). N = 
30 (22 female, 8 male) 73.3% 
female. 
20% Depression 
(GDS) Anxiety 
(HAM-A)         
 
One week follow up  
Reduction in anxiety 
(p<.001) and 
depression (p<.001) 
compared to controls                              
Six month follow up                
Reduction in anxiety 
(p<.002) and 
depression (p<.006) 
compared to controls         
 
Low 
Spector 
et al, 
2015 
RCT (2 arm); 
Baseline, 
week 15 and 
6 months 
Treatment (individual 
intervention): 
Cognitive Behavioural 
Therapy (21) 
 
Control: Treatment As 
Usual (18) 
 
Ten weekly 60-minute 
sessions 
The intervention 
was manualised 
(Charlesworth et 
al, 2014) 
 
Fidelity checks 
were within 
acceptable limits.  
Intention to treat 
analysis was 
used 
People with dementia with mild 
to moderate cognitive 
impairment (DSM-IV and score 
of 0.5, 1 or 2 on CDR) and 
symptoms of anxiety (RAID 
score ≥ 11) that has carer 
willing to participate in therapy 
Secondary care outpatient NHS 
services in UK             
M = 78.5 (SD = 7.02) years                                         
N = 50 (30 female, 20 male)   
22% Anxiety (RAID)   
Depression 
(CSDD)     
Anxiety and 
Depression 
(HADS) 
One week follow up   
Reduction in anxiety 
(p<.05) on RAID and 
depression on CDSS 
(p<.05) compared to 
controls                                  
Six month follow up       
Reduction in anxiety 
(p<.05) and 
depression (p<.05) 
compared to controls 
Low 
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AMS = Alzheimer’s Mood Scale, BDI = Beck Depression Inventory, CSDD = Cornell Scale for Depression in Dementia, 
DMAS = Dementia Mood Assessment Scale, GAI = Geriatric Anxiety Inventory, GDS = Geriatric Depression Scale, HAM-A 
= Hamilton Anxiety Rating Scale, HDRS = Hamilton Rating Scale for Depression, NPI-A = Neuropsychiatric Inventory-
Anxiety, OAS = Observed Affect Scale, MADRS = Montgomery-Asberg Rating Scale, RAID= Rating Anxiety in Dementia 
Scale. 
Description of Studies 
 Participants were selected from populations in the USA, UK, Hong Kong 
and France. They were recruited from nursing homes, research centres and 
outpatient services. Seven studies recruited participants with dementia; five of these 
studies specified mild to moderate cognitive impairment in their inclusion criteria. 
No study met criteria for MCI. Participants ranged from 73 to 88 years and the 
proportion of females in each study ranged from 47% to 89%. Table 1 outlines the 
demographic details of the included studies. 
All studies used a randomised control design. One study was not described 
as an RCT but it met criteria for being an RCT and was included in the review 
(Williams & Tappen, 2008). Interventions tested in the studies included cognitive 
behavioural therapy (Spector et al., 2015; Stanley et al., 2013), pleasant events 
behaviour therapy and problem solving behaviour therapy (Teri, Logsdon, Uomoto, 
& McCurry, 1997), music therapy (Guétin et al., 2009), Tai-Chi, Mahjong1 (Cheng, 
Chow, Yu, & Chan, 2012), exercise (Williams & Tappen, 2008) and a 
                                                
1 Mahjong is a table-top game using tiles. 
Stanley 
et al 
2013 
RCT (2 arm); 
pre-post; 6 
month follow 
up 
 
 
Treatment (individual 
intervention): 
Cognitive Behavioural 
Therapy (16) 
Control: Treatment As 
Usual (16) 
12 sessions in first 3 
months, duration not 
reported. Up to 8 brief 
telephone booster 
appointments during 3-6 
months. 
The intervention 
was manualised 
Fidelity to the 
model: the 
therapy sessions 
were audio 
recorded and 
rated. They 
showed adequate 
and competency  
Intention to treat 
analysis was 
used 
People with a diagnosis of 
dementia with mild-to-
moderate cognitive impairment 
and symptoms of anxiety (NPI 
score ≥ 4) 
Older adult outpatient services 
in the USA 
M = 78.6 (SD = 9.68) years                                
N = 32 (13 Male, 19 Female) 5 
 
4% Depression 
(GDS)                  
Anxiety (NPI-
Anxiety, RAID, 
GAI)  
One week follow up  
Reduction in anxiety 
compared to controls 
(p<.05) using the 
RAID. 
No significant effect 
on anxiety using the 
NPI    
Three month follow 
up Reduction in 
anxiety compared to 
controls (p<.05)  
No significant effect 
on anxiety using the 
NPI Anxiety at 6 
months 
Unclear 
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multicomponent intervention which incorporated CBT techniques, reminiscence, 
question asking reading, environmental supports and behavioural activity programs 
(Bailey, Stevens, LaRocca, & Scogin, 2016). Five studies tested an individual 
intervention and two studies tested a group intervention. The length of intervention 
ranged from bi-weekly sessions for six-weeks to 16 weekly sessions. Four studies 
used a wait list control or TAU and three studies used an active treatment condition 
such as reading sessions, conversation session and handicrafts. Six studies detailed 
the training or profession of the therapist, however one study did not provide this 
information (Guétin et al., 2009).  
Depression was measured using the 15 item Geriatric Depression Scale 
(GDS) (Yesavage & Sheikh, 1986), the 24-item Hamilton Rating Scale for 
Depression (HRSD) (Hamilton, 1960), the 30-item GDS scale (Yesavage et al., 
1982) and the 19- item Cornell Scale for Depression in Dementia (CSDD) 
(Alexopoulos, Abrams, Young, & Shamoian, 1988). Larger scores indicate greater 
levels of depression. Cheng and colleagues (2012) used the GDS as their primary 
measure of depression. However, the GDS is not a valid tool for assessing 
depression in PWD (Kørner et al., 2006). Secondary measures of depression were 
used in two studies (Teri et al., 1997; Williams & Tappen, 2008) but they were not 
included in the review. These were the Beck Depression Inventory (Beck, Steer, & 
Carbin, 1988) and Dementia Mood Assessment Scale (Sunderland & Minichiello, 
1996).  
Anxiety was measured using the 18-item clinician rated Rating Anxiety in 
Dementia (RAID) scale (Shankar, Walker, Frost, & Orrell, 1999) and the 14-item 
Hamilton Anxiety Rating Scale (HAM-A)(Hamilton, 1959). Higher scores on these 
scales indicate higher levels of anxiety. Secondary measures of anxiety were used in 
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two studies but they were not included in the review. Stanley and colleagues (2013) 
also used the anxiety subscale of the Neuropsychiatric Inventory Questionnaire 
(Cummings et al., 1994), Penn-State Worry Questionnaire (Meyer, Miller, Metzger, 
& Borkovec, 1990) and the Geriatric Anxiety Inventory (Pachana et al., 2007). 
Spector and colleagues (2015) used the Hospital Anxiety and Depression Scale 
(Zigmond & Snaith, 1983).  
Quality Assessment and Risk of Bias  
The Cochrane’s Risk of Bias tool was used to rate the quality of each study.   
Risk of Bias Items.  The ‘risk of bias graph’ illustrates, in percentages, each 
risk of bias item for all the included studies (see Figure 2).  
 
 
Figure 2: Risk of bias graph 
 
Overall, 43% (n=3) of the studies did not report sufficient detail to determine 
the bias for both random sequence generation and allocation concealment. All the 
studies (n=7) were unable to blind participants from the treatment conditions, due to 
the nature of the interventions. Most of the studies (86%, n=6) provided details that 
the assessors, completing baseline and follow-up assessments, were blinded to 
treatment allocation; and were deemed to have a low risk of detection bias. All the 
studies were considered to have a low risk of bias for outcome data being 
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incomplete and over 50% (n=4) reported intention-to-treat (ITT) data. Most of the 
studies (71%, n = 5) were deemed to have a low risk of selective reporting because 
they reported all pre-specified outcomes; whilst two studies did not report the results 
of one or more pre-specified outcomes. There were no other biases identified for the 
seven studies. 
Risk of Bias Summary.  The ‘risk of bias’ summary graph details the 
assigned risk of bias for each item for each included study (see Figure 3). 
Studies were deemed as having a high risk of bias if they were rated as high 
risk of bias in any area, except for the blinding of participants. Studies that were 
deemed to have unclear risk in one or more areas, were assessed as having an 
unclear risk of bias. Studies that rated all risk of bias domains as low risk, apart from 
the blinding of participants, were classified as low risk of bias. 
Two studies were judged as having a low risk of bias in all domains apart 
from the blinding of participants (Guétin et al., 2009; Spector et al., 2015). Two 
studies were classified as unclear risk of bias, due to limitation such as uncertainties 
about allocation concealment (Stanley et al., 2013) and random sequence generation 
(Cheng et al., 2012). Three studies were classified as high risk of bias, due to 
selective reporting (Teri et al., 1997; Williams & Tappen, 2008) and not blinding the 
outcome assessment (Bailey et al., 2016). 
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= low risk of bias,  = unclear risk of bias,  = high risk of bias 
Figure 3: Risk of bias Summary 
Meta-Analyses 
Interventions for Depression.  Four studies compared depression outcomes 
for psychosocial interventions and control interventions, within one week of 
completing treatment. These included group interventions (Bailey et al., 2016; 
Cheng et al., 2012) and an individual intervention (Williams & Tappen, 2008). The 
data from studies using a three-arm design (Cheng et al., 2012; Williams & Tappen, 
2008) were adapted to be used in the meta-analysis. There were similarities in the 
intervention arms for the studies that used a three-arm design; therefore, the 
intervention arms were pooled together for the meta-analyses. For instance, the 
intervention arms were walking and exercise in Williams and colleagues (2008) and 
Mahjong and Tai Chi were both leisure activities in Cheng and colleagues (2012). 
One study did not provide enough information to be included in the meta-analysis 
and will be discussed separately (Teri et al., 1997). 
Figure 4: Forest plot of comparison: Depression outcomes one-week post 
intervention.  
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The total effect size, using a random-effects model, for the three data sets 
with 132 participants, was 0.71; (95% confidence interval (CI), -1.08 to -0.35). This 
indicated a significant (p <. 0001) medium to large effect for psychosocial 
interventions reducing symptoms of depression in PWD, within one week of 
completing treatment. Cheng and colleagues’ (2012) reported a medium to large 
between groups effect size favoring Tai-Chi/Mahjong, as compared to an active 
control intervention (handicrafts) (SMD = -0.73, 95% CI: -1.44 to -0.01). Bailey and 
colleagues (2016) had a large between group effect size favoring a multicomponent 
intervention, as compared to treatment as usual, using the CSDD to measure 
depression (SMD = -.99, 95% CI: -1.58 to -.41). However, there was no significant 
effect when the GDS was used to measure depression. There was a medium between 
groups effect size when the GDS was used in the analysis. However, the analysis 
using CSDD was used because it is validated measure of depression in PWD. One 
study (Williams & Tappen, 2008) reported that exercise and walking was neither 
superior nor inferior to an active control intervention (conversation). There was no 
heterogeneity between studies (I2 = 0%), which suggests that the effect is accurate 
and can be trusted (see Figure 4). Teri and colleagues (1997), the study not included 
in the meta-analysis, found a significant reduction in depression scores in the 
treatment groups (pleasant events behaviour therapy and problem solving behaviour 
therapy), as compared to the control groups, on the HRSD (p < .001) and CSDD (p 
< .001). 
Six-month follow up depression data was gathered for two studies (Cheng et 
al., 2012; Teri et al., 1997), although only one study provided adequate information 
to be included in the meta-analysis (Cheng et al., 2012). Cheng and colleagues 
(2012) reported that Tai-Chi/Mahjong was neither superior not inferior to the control 
		 26	
intervention. Teri and colleagues (1997) found that the significant effect was 
maintained on the HRSD (p < .001) and CSDD (p < .001). 
Interventions on Anxiety. 
End of Treatment.  Three studies compared the anxiety outcomes for 
psychosocial interventions and control interventions, within one week of completing 
treatment. These were all individual interventions (Guétin et al., 2009; Spector et al., 
2015; Stanley et al., 2013). 
 
Figure 5: Forest plot of comparison: Anxiety outcomes one week post intervention. 
 
The overall effect size, using a random-effects model, of the three data sets 
with 97 participants, was -1.33; (95% confidence interval CI, -2.21 to -0.44). This 
indicated a large significant effect (p < .005) for psychosocial interventions for 
reducing symptoms of anxiety for PWD, within one week of completing the 
intervention. Two studies had a large between groups effect size favoring 
psychosocial interventions (CBT and music therapy), as compared to a control 
intervention (Guétin et al., 2009; Stanley et al., 2013). One study reported a medium 
to large between group effect size favoring a psychosocial intervention (CBT), as 
compared to a control intervention (Spector et al., 2015). There was a high amount 
of heterogeneity between studies (I2 = 72%) (see Figure 5), which suggests that the 
effect may not be accurate and should be interpreted with caution. 
Six-Month Follow Up.  Two studies compared the anxiety outcomes for 
psychosocial interventions and control interventions, at 3 and 6 month follow up. 
These were both group interventions (Guétin et al., 2009; Stanley et al., 2013).  
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Figure 6: Forest plot of comparison: Anxiety outcome at six month follow up. 
The overall effect size of the two data sets with 56 participants, was -1.06 
(95% CI, -1.32 to -0.67), indicating that there was a significant large effect (p < .05) 
for psychosocial interventions reducing symptoms of anxiety for PWD. There was a 
medium to high amount of heterogeneity between studies (I2 = 64%), which 
suggests that the effect should be interpreted with caution (see Figure 6). 
Discussion 
Summary of Results 
This review compared the effectiveness of psychosocial interventions for 
depression and anxiety in PWD or MCI, who were depressed or anxious. Seven 
RCTs (4 for depression, 3 for anxiety) were selected for narrative review and six of 
these studies (3 for depression, 3 for anxiety) were included in the meta-analyses.  
Depression.  A meta-analysis, from three RCTs, suggests that certain 
psychosocial interventions (Mahjong/Tai Chi, an exercise/walking intervention and 
a multicomponent intervention) are effective at improving depression symptoms in 
PWD, over the course of treatment. However, only one of these studies collected 
follow-up data (Cheng et al., 2012) and the treatment gains were not maintained 
(Cheng et al., 2012). The studies included in these meta-analyses only recruited 
participants from nursing homes. One study (Teri et al., 1997), not included in the 
meta-analysis, recruited participants from a community sample. It found that 
pleasant events behaviour therapy and problem solving behaviour therapy were 
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effective at improving depression symptoms at the end of treatment; and this effect 
was maintained at follow up.  
Anxiety.  The meta-analysis from three RCTs, suggests that psychosocial 
interventions (music therapy and CBT) are effective at reducing anxiety symptoms 
in PWD at the end of treatment (Guétin et al., 2009; Spector et al., 2015; Stanley et 
al., 2013). These three studies were also individually effective at improving anxiety 
symptoms at the end of treatment. The meta-analysis, from two RCTs (music 
therapy and CBT), showed that treatment gains were maintained at follow-up 
(Guétin et al., 2009; Stanley et al., 2013). More specifically, music therapy 
maintained the effect (Guétin et al., 2009) and CBT did not (Stanley et al., 2013).  
Strengths and Limitations 
There was variation in the included studies, in terms of the quality of studies, 
population studied, the nature, intensity and frequency of the psychosocial 
intervention, which limited the conclusions made about specific type of 
interventions for specific populations. There was limited heterogeneity detected 
between study effects for the meta-analyses for depression. There was a large 
amount of heterogeneity between study effects for the meta-analyses for anxiety, 
which suggests that the effect should be interpreted with care. However, the statistic 
that quantifies heterogeneity (I2) can be imprecise and biased when used in small 
meta-analyses, and should be interpreted with caution (Von Hippel, 2015). 
The quality of the studies’ methodology and reporting is consistent with the 
findings of previous reviews (Orgeta et al., 2014), which suggested that the quality 
of evidence is mixed, as a large proportion of the included studies were rated as 
being unclear or low quality. The quality of the studies, for depression interventions, 
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was rated as poor, with two studies having a high risk of bias and one having an 
unclear risk of bias. The quality of studies, for anxiety interventions, was rated as 
good. The risk of bias was rated as low for two studies and unclear for one study; 
and all studies used intention to treat analysis. Future RCTs are recommended to use 
a rigorous methodology and report the relevant information, as detailed in the 
Consolidated Standards of Reporting Trials (CONSORT). 
Around half of the studies did not provide details of fidelity checks (57%, n 
= 4); therefore, it is difficult to determine if facilitators adhered to the intervention 
protocol. Three studies did not detail information about power calculations therefore 
it was unclear if the sample size was sufficient to detect an effect (Bailey et al., 
2016; Teri et al., 1997; Williams & Tappen, 2008). The sample sizes in the study 
were small, ranging from 25 to 68 participants. Therefore, future research needs to 
recruit larger sample sizes. A large proportion of the studies (57%, n=4) used a 
“treatment as usual” or “waitlist” control group, as compared to an active control 
group. It would be beneficial for future research to use an active control group to 
control for the placebo effect (Boot, Simons, Stothart, & Stutts, 2013). 
One study did not describe itself as an RCT, although it met criteria for being 
an RCT and was included in the review (Williams & Tappen, 2008). It was also 
unclear whether this individual intervention (exercise and walking) met criteria for 
being a psychosocial intervention. However, the aim of the intervention was to 
reduce symptoms of depression using exercise and walking, similar to behavioural 
activation (Veale, 2007), therefore it was deemed to be a psychosocial intervention. 
Nevertheless, the data was reanalysed without this study and it did not change the 
overall results. It was the only intervention for depression that did not significantly 
improve symptoms of depression, one-week post intervention.  
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Highly sensitive search strategies for identifying RCTs were used to identify 
studies (Eady et al., 2008; Higgins & Green, 2011; Wong et al., 2006). To minimise 
bias, it is recommended that two people complete the literature searches, the 
extraction of suitable studies and the assessment of risk of bias. However, due to 
limited resources, the student completing the review completed these tasks, with 
final studies agreed with her research supervisor. 
Implications for Future Research 
Depression.  There is some evidence to suggest that psychosocial 
interventions can reduce symptoms of depression in PWD who are depressed. These 
findings are similar to other reviews (Orgeta et al., 2014; Regan & Varanelli, 2013; 
Teri et al., 2005). However, these findings cannot be generalised to all PWD 
because the studies, in the meta-analysis for depression, only recruited participants 
from nursing homes. Therefore, research is required on interventions for depression 
for PWD in community samples. 
Most of the studies included in the meta-analyses for depression did not 
measure depression symptoms in participants several months after the intervention; 
and the one study that did, found that the improvements were not maintained. 
Therefore, future research should aim to collect longitudinal data to inform the 
longer-term benefits of interventions for PWD. The only study that continued to 
show beneficial effect, a considerable amount of time after the end of the 
intervention, was the pleasant events behaviour therapy and problem solving 
behaviour therapy (Teri et al., 1997), which was not included in the meta-analysis. 
This study recruited participants from a community sample and their mean age was 
younger than the studies included in the meta-analysis; potentially suggesting that 
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the benefits of interventions on depression symptoms may be better maintained in 
younger PWD in community samples, a potential focus for future research.  
Group interventions (multicomponent intervention, Mahjong/Tai Chi), were 
found to be effective at improving depression symptoms (Bailey et al., 2016; Cheng 
et al., 2012), although the individual intervention (exercise/walking) (Williams & 
Tappen, 2008) was not. Research suggests that individual interventions for 
depression are superior to group interventions in working ages adults (Huntley, 
Araya, & Salisbury, 2012), however these results suggest that there may be different 
trends in a dementia population. In a qualitative study, nursing home residents 
preferred that treatments for depression focused on reducing isolation, as opposed to 
individual psychotherapy (Choi, Ransom, & Wyllie, 2008). Only one of the studies 
(Cheng et al., 2012) compared the group treatment condition (Mahjong/Tai Chi) to a 
group control condition (handicrafts). While this study did find a benefit of the 
intervention immediately after treatment, this effect was not present at six-months 
follow up. Future research should control for the benefits of social contact when 
testing group interventions.  
Anxiety.  All the included studies had a medium-to-large (Spector et al., 
2015) or large effect size (Guétin et al., 2009; Stanley et al., 2013). Therefore, music 
therapy and CBT interventions for PWD with anxiety should be prioritised for 
research. The evidence for music therapy is perhaps particularly strong as it used an 
active control group (reading group) and it was also found to maintain its large 
effect at six month follow up (Guétin et al., 2009). This maybe the result of 
participants being offered more sessions (16 sessions), as compared to CBT (10-12 
sessions) (Spector et al., 2015; Stanley et al., 2013). Therefore, it may be beneficial 
for future research to investigate if interventions that provide more sessions to PWD 
		 32	
are more effective than those that provide fewer sessions. 
Implications for Practice 
Depression.  The multicomponent intervention (Bailey et al., 2016) had the 
largest effect size for depression interventions, despite using intention to treat 
analysis. However, the study was rated as having a high risk of bias. This 
intervention incorporated CBT techniques, reminiscence, environmental supports 
and a behavioural activity programs. This intervention may be beneficial for PWD 
residing in nursing homes. Future research should identify which component of this 
intervention was the agent for change. 
Half of the interventions (multicomponent intervention, Mahjong/Tai Chi) 
had low attrition rates (Bailey et al., 2016; Cheng et al., 2012), which is positive for 
practice. However, attrition rates in RCTs may not be comparable to attrition rates in 
normal practice therefore it is recommended that the implementation of these 
interventions are tested in services. 
Anxiety.  Music therapy (Guétin et al., 2009) was found to improve anxiety 
for PWD residing in nursing homes, with a large effect size. Whereas, CBT was 
found to improve anxiety for PWD from a community setting, with a medium-to-
large (Spector et al., 2015) and large (Stanley et al., 2013) effect size. Music therapy 
and CBT interventions for PWD with anxiety should be prioritised for practice. 
These interventions may be particularly effective because they focus on thoughts 
and emotions. CBT is specifically designed to understand emotions, thinking styles 
and behaviours associated with anxiety (Beck et al., 1963). Music therapy 
encourages emotional expression to  help  develop an understanding of one’s 
emotions (Guétin et al., 2009).  
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Completeness of Evidence 
Most of the included studies recruited participants with mild to moderate 
dementia. The review did not identify any RCTs that were aimed at people with 
MCI. There were four potential studies that were identified; although they recruited 
participants with cognitive impairment which did not meet the established criteria 
for MCI (Alexopoulos et al., 2011; Areán et al., 2010; Kiosses et al., 2015a; 
Kiosses, Arean, Teri, & Alexopoulos, 2010). As depression and anxiety have been 
found to increase the risk of dementia in people with MCI (Cooper et al., 2015), it is 
important that psychosocial interventions for depression and anxiety are available in 
this population. One study (Kiosses et al., 2015b) was excluded because the sample 
consisted of participants with definite or probable dementia, and it did not specify 
the proportion of participants with probable dementia. 
Seven studies, that tested psychosocial intervention for PWD, were 
identified. The depression outcomes for three studies and the anxiety outcomes for 
three studies were pooled together. However, data from one study failed to be 
obtained despite contacting the author (Teri et al., 1997). Therefore, the study could 
only be included in the narrative review.  
Conclusion 
This systematic review with meta-analyses was distinctive because it aimed 
to compare the efficacy of psychosocial interventions on symptoms of depression 
and anxiety in PWD or MCI who were depressed and/or anxious. The review did not 
identify any RCTs that were aimed at people with MCI therefore this population 
should be targeted for future research. Preliminary evidence suggests that certain 
psychosocial interventions are effective at improving depression and anxiety 
symptoms in PWD over the course of treatment. The quality of evidence was good 
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for the interventions targeting anxiety, whereas it was poor for the interventions 
targeting depression. However, it was recommended that music therapy and CBT 
interventions for PWD and anxiety should be prioritised for research and practice. 
The psychosocial interventions included in the review did not report any adverse 
events, which suggest that the observed effect is beneficial to PWD. Future research 
would be improved with carefully targeted interventions, adequately powered 
samples and active control groups. 
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Abstract 
Aims: Depression and anxiety have been identified as specific targets for 
psychosocial interventions for people with dementia (PWD). This feasibility study 
aimed to do exploratory analysis on whether an adapted Mindfulness Based 
Cognitive Therapy (MBCT) group would lead to greater reductions in symptoms of 
depression and anxiety, in PWD who are depressed, as compared to treatment as 
usual (TAU).  
Method: A feasibility randomised controlled trial (RCT) was used. PWD that were 
experiencing depression were recruited from memory clinics. Twenty participants 
were randomised to either an adapted MBCT group (n=10) or TAU (n=10).  This is 
a joint project completed with Jacob Payne (JP). Measures of depression, anxiety, 
quality of life (QOL) and cognition were assessed at baseline and follow-up. 
Measures of depression and anxiety are analysed and reported here. JP reports on the 
feasibility of the intervention and measures of QOL and cognition. 
Results: The MBCT group did not show significant reductions in depression or 
anxiety at follow-up, as compared to TAU. 
Conclusions: There is inadequate evidence to recommend this adapted MBCT 
intervention for PWD in memory clinics. The MBCT intervention needs 
redevelopment and piloting before further testing in an RCT. 
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Introduction 
Dementia 
Dementia is a neurodegenerative syndrome characterised by the progressive 
deterioration of cognitive functioning and activities of daily living (Albert et al., 
2011; WHO, 2016). The global prevalence of dementia was approximately 46.8 
million in 2015; and this is predicted to double by 2050 (Prince et al., 2015).  
Depression and Anxiety 
Depression and anxiety are common in PWD (Lyketsos et al., 2002); with 
the prevalence estimated to be between 20% and 30% for depression (Enache, 
Winblad, & Aarsland, 2011) and between 5% and 21% for anxiety (Ferretti, 
McCurry, Logsdon, Gibbons, & Teri, 2001; Savva et al., 2009; Starkstein, Jorge, 
Petracca, & Robinson, 2007). In PWD, depression and anxiety are linked with 
negative outcomes, such as reduced quality of life, worsened cognition, increased 
functional impairment, behavioural disturbance and mortality rates (Banerjee et al., 
2011; Butters et al., 2008; Kales, Chen, Blow, Welsh, & Mellow, 2005; McCurry, 
Gibbons, Logsdon, & Teri, 2004; Rapp et al., 2011; Starkstein et al., 2007).  
Interventions for Depression and Anxiety 
Psychiatric medications, that are prescribed to treat depression and anxiety, 
are associated with adverse side effects (Stomski, Morrison, & Meyer, 2016); and 
there has been limited support for their effectiveness in PWD (Leong, 2014; Moretti, 
Torre, Antonello, & Pizzolato, 2006; Sepehry, Lee, Hsiung, Beattie, & Jacova, 
2012). Non-pharmacological interventions for depression and anxiety, in PWD, have 
been identified as a potential areas for development (Cooper, Sommerlad, Lyketsos, 
& Livingston, 2015), with the government promising to improve access to evidence 
based therapies (Department of Health 2011). There are currently limited evidenced 
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based non-pharmacological treatments currently available for PWD who are 
depressed. 
Non-pharmacological Interventions.  A Cochrane review, including a 
meta-analysis, found that psychological treatments were effective at improving 
depression symptoms in PWD (Orgeta, Qazi, Spector, & Orrell, 2014). The studies 
included in this review did not require the participants to meet criteria for depression 
at baseline. The challenge of designing psychosocial interventions for PWD is 
making the appropriate adaptations for a range of possible cognitive impairments, 
such as memory, comprehension, learning capacity, orientation, attention and 
language. 
Mindfulness with Older Adults.  Mindfulness involves deliberately holding 
one’s attention on the present moment, without passing judgment (Kabat-Zinn, 
2006). Mindfulness has been incorporated into structured group programmes such as 
Mindfulness Based Cognitive Therapy (MBCT) (Segal, Williams, & Teasdale, 
2002) and Mindfulness Based Stress Reduction (MBSR) (Kabat-Zinn, 2013). 
Mindfulness has been found to improve depression symptoms in older adults 
without a recognised cognitive decline (Gallegos, Hoerger, Talbot, Moynihan, & 
Duberstein, 2013; Moss et al., 2015). 
Mindfulness with PWD. In a quasi-experimental study, an adapted MBSR 
intervention significantly reduced depressive symptoms in people with progressive 
cognitive decline (dementia, mild cognitive impairment and memory loss) living in 
the community (Paller et al., 2015). In a feasibility RCT for PWD in care homes, a 
mindfulness based intervention (MBI) improved quality of life and was deemed a 
feasible intervention for PWD (Churcher Clarke, Chan, Stott, Royan, & Spector, 
2017). There were no significant changes in depressive symptoms, although there 
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may have been less scope for change because it did not recruit PWD who were 
depressed. A third of participants who met criteria for depression in the MBI group 
were no longer in the clinical range at follow-up; whereas this change was not 
evident in the TAU group. Based on this, the authors suggested that interventions 
could be designed for PWD and depression. The residential sample in this study was 
more impaired than community samples; therefore, the participants may have not 
understood some of the mindfulness techniques. This population was more 
dependent on support and they typically had no carers available to support them. 
Therefore, the intervention may be more suitable for a higher functioning 
community sample. It recommended that future research should investigate the 
feasibility of running a mindfulness group for PWD, with milder cognitive 
impairment, in a community setting.  
Community Services 
There are currently no clear guidelines about which services (e.g. Increasing 
Access to Psychological Therapies (IAPT) or memory clinics) should see people 
with mild dementia, whose primary concern is depression. Memory clinics are the 
specialist outpatient services that offer assessment, early diagnosis, treatment and 
advice to people with memory disorders such as dementia (Lindesay, Marudkar, van 
Diepen, & Wilcock, 2002). They focus on providing interventions for cognition, as 
opposed to psychological interventions for depression. However, memory clinics 
offer a unique opportunity to recruit people with mild dementia and depression in a 
community setting. Research in this population could inform primary care services, 
whose main aim is to provide psychological interventions (e.g. IAPT), about 
evidenced based interventions for depression in PWD. 
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Current Study 
Joint Project and Joint Aims. This feasibility study was part of a joint D.Clin.Psy. 
project completed with Jacob Payne (JP). The primary aim of this study is to 
establish the feasibility of doing an RCT for an adapted MBCT programme (e.g. 
acceptability, recruitment, retention, adherence), which is reported by JP. The 
secondary aim is to assess whether an adapted MBCT group intervention will lead to 
greater reductions in symptoms of depression, anxiety, quality of life (QOL) and 
cognition in PWD who are depressed, as compared to treatment as usual (TAU). 
Measures of depression, anxiety, quality of life (QOL) and cognition were assessed 
at baseline and follow-up. JP reports on the measures of quality of life and 
cognition. Deirdre Noone (DN) reports on the impact of the intervention on 
depression and anxiety. Appendix C details JP and DN’s contributions to the 
feasibility RCT. 
Aims/Hypotheses.  As this is a feasibility study, it is expected that the study will be 
insufficiently powered to detect an effect. The aim of this section of the study is to 
do an exploratory analysis to assess whether an adapted MBCT group intervention 
will lead to greater reductions in symptoms of depression and anxiety in PWD who 
are depressed, as compared to treatment as usual (TAU).  
Methods 
Design 
A single-blind, multicentre, feasibility RCT of an adapted MBCT group 
versus TAU for PWD who are depressed. The research protocol has been published 
(Aguirre et al., 2017). 
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Participants   
The study selected participants from two memory clinics in Greater London between 
June 2016 and April 2017. These memory clinics were chosen based on professional 
contacts within the research team. 
Participant inclusion criteria.  Participants were considered for inclusion in 
the study if they: 
(a) met the DSM-IV criteria for dementia (American Psychiatric Association, 
2000); 
(b) were in the mild stages of dementia, as indicated by a score of 18 or above 
on the Mini Mental State Examination (MMSE) (Folstein, Folstein, & 
McHugh, 1975); 
(c) met criteria for depression, as indicated by a score of 9 or above on the 
Patient Health Questionnaire	(Kroenke, Spitzer, & Williams, 2001); 
(d) were functionally able to attend and participate in the group (i.e. able to 
communicate in English, to engage in the group, physically able to attend 
group, able to concentrate in a 90-minute session), which was based on 
judgement of care coordinator and blind assessor. 
Participant exclusion criteria.  Participants were excluded if they: 
(a) did not have capacity to consent for themselves; 
(b) presented with suicidal intent that needed immediate intervention; 
(c) had a diagnosis of a learning disability; 
(d) were involved in other psychosocial intervention research; 
(e) had a diagnosis of psychosis; 
(f) were within two months of a bereavement. 
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Procedure  
Recruitment of Participants.  The principal researchers attended regular 
memory clinic team meetings, where they provided the team with details about the 
study, such as information about the intervention and inclusion criteria. The staff 
identified and discussed the study with suitable patients; and provided them with an 
information sheet (Appendix D1). If they were interested, they met with a researcher 
to establish whether they would like to participate, and if so obtained informed 
consent (Appendix D2). The participant was asked if they would like to invite a 
carer to complete some questionnaires. The carer was provided with an information 
sheet (Appendix D3); and informed consent (Appendix D4) was obtained the day of 
the assessment. The information sheets and consent forms from a previous study 
(Churcher Clarke et al., 2017) were adapted for the purposes of this study. 
An assessor, independent from the group facilitators, met participants for an 
assessment within two weeks of the group starting and finishing. The initial 
assessment collected information on demographics, cognitive functioning (as 
measured by the MMSE) and levels of depression (as measured by the Patient 
Health Questionnaire). A full assessment was completed for those participants who 
met the inclusion criteria. The assessor was blind to which group the participant was 
allocated.  
Randomisation.  An independent researcher created a randomisation 
sequence for the study using online software sealedenvelop.com. The independent 
researcher allocated participants to treatment conditions via email. The assessors, 
that completed the outcomes measures with participants, were blind to the 
randomisation sequence and allocation of participants until data analysis was 
completed. Participants were randomised using a one-to-one ratio. 
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Intervention and Control Arms 
MBCT Group.  Participants were invited to attend a weekly MBCT group 
for eight weeks, which included skills training and in-class practice. The sessions 
were 90 minutes long. A psycho-education session about MBCT was offered to 
participants and their carers before the start of the group.  
The MBCT for the prevention relapse in recurrent depression (Segal et al., 
2002) was adapted for PWD. It was guided by: (1) MBCT literature (Bartley, 2011; 
Segal et al., 2002; Teasdale, Williams, & Segal, 2014; Williams & Penman, 2012) 
and consultation with MBCT facilitators from the Oxford Mindfulness Centre 
(OMC) and senior professionals working with PWD. The structure of the sessions 
included the use of regular summaries. Participants were encouraged to talk about 
their cognitive difficulties and symptoms of depression. Shorter meditations (10-20 
minutes) were also used, as compared to the original protocol (25-40 minutes). 
There were summaries provided at the beginning and end of sessions to help 
consolidate learning, which was informed by literature on CBT for older adults 
(Simon, Cordás, & Bottino, 2015; Spector et al., 2015; Stanley et al., 2013).  
The mindfulness exercises used in the sessions included: body scan, mindful 
eating, mindful stretching, and mindfulness exercises that had a specific focus 
(breath, body, sounds, emotions, thoughts). Home practice involved ‘formal’ 
practices (listening to the audio recording of mindfulness exercises) and ‘informal’ 
practices (incorporating mindfulness into routine daily experiences, such as eating, 
walking and brushing teeth). Participants were asked to complete a formal practice 
five times a week; and informal practice for an additional 10–15 minutes a day. 
Participants were asked to use homework logs to record information about their 
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formal and informal practice; such as the audio-recording they used and the length 
of practice. Each participant was contacted each week by a facilitator to support 
home practice. The protocol is detailed in Appendix B. 
Control Group.  The TAU group received usual appointments with their 
health care professionals. 
Facilitators’ Experience   
There was an MBCT group running at each of the two memory clinics. Each 
of the groups were facilitated by two appropriately trained facilitators. There were 
two level two trained MBCT facilitators leading one group. There was one level one 
MBCT trained facilitator leading the other group. The latter group was assisted by a 
Trainee Clinical Psychologist (author) that had completed the 8-week MBCT 
programme. In addition to peer supervision, an associate teacher from the Oxford 
Mindfulness Centre (OMC) provided regular supervision. 
Measures 
Outcome measures were completed at baseline (within two weeks before the 
intervention) and follow up (within two weeks after the intervention). Demographic 
details were collected, such as age, gender, ethnicity, marital status, education and 
dementia type. Outcome measures were used to assess cognitive function, 
depression and anxiety. There were two outcome measures used for both depression 
and anxiety. Some measures were included because they are used clinically in 
primary care services (e.g. IAPT) and other dementia specific measures were used 
because they are the ‘gold standard’ for assessing depression and anxiety in PWD. 
Cognitive function.  The Mini Mental State Exam (MMSE) (Folstein et al., 
1975) involves the participant doing 11 tasks (orientation to time and place, 
attention, recall, language and visual construction), with scores ranging from 0-30. 
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Cognitive impairment was categorised as severe for scores between 0-17, mild for 
scores between 18-24 and not present for scores between 24-30 (Tombaugh & 
McIntyre., 1992). The MMSE is an widely used tool for assessing cognition in 
dementia; and the reliability and validity are satisfactory (Woodford & George., 
2007). It was used as a screening tool for inclusion. Participants were eligible if they 
scored 18 and above. 
Depression.  
Patient Health Questionnaire.  Patient Health Questionnaire (PHQ-9) 
(Kroenke et al., 2001) is a nine-item questionnaire based on the DSM-IV depression 
diagnostic criteria, with each item rated 0–3 (0=not at all, 1 = several days, 2 = more 
than half the day, 3 = nearly every day), with scores ranging from 0-27. The severity 
of depression in indicated by the score (0–4, minimal depression; 5–9, mild 
depression;10–14, moderate depression; 15–19, moderately severe depression; 20–
27, severe depression). The PHQ-9 has been shown to be acceptable to service users 
in memory clinics, alongside being brief and easy to complete (Hancock & Larner, 
2009). It was used as a screening tool for inclusion. The PHQ-9 is commonly used 
in primary care services (e.g. IAPT). 
Cornell Scale for Depression in Dementia.  The Cornell Scale for 
Depression in Dementia (CSDD) (Alexopoulos, Abrams, Young, & Shamoian, 
1988) is a 19 item clinician-administered outcome measure used to assess 
depression. Information was gathered from interviews with the participant and 
an informant (e.g. family member) and this information is used to rate five areas 
of depression (mood-related signs, behavioural disturbance, physical signs, 
biological functions and ideational disturbance). Each item had a three-point 
scale (0=absent, 1 = mild or intermittent, 2 = severe) with a maximum score of 
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57. Significant depressive symptoms are indicated as a score of 8 and above 
(Alexopoulos et al., 1988; Burns, 2002). The CSDD is deemed to be the ‘gold 
standard’ for assessing depressive symptoms in PWD (Kørner et al., 2006; 
Sheehan, 2012). 
Anxiety. 
Rating Anxiety in Dementia scale (RAID).  RAID (Shankar, Walker, Frost, 
& Orrell, 1999) is an 18-item clinician-administered outcome measure. Information 
is gathered from interviews with the participant and an informant (e.g. family 
member) and this information is used to rate four areas of anxiety (worry, 
apprehension, vigilance, motor tension, autonomic hypersensitivity). Each item is 
rated on a four-point scale (0=absent, 1 = mild or intermittent, 2 = moderate, 3= 
severe) with a maximum score of 54. A score of 11 and above was the cut off for 
clinical anxiety (Shankar et al., 1999). The RAID is deemed to be the best measure 
for measuring anxiety in this population (Seignourel, Kunik, Snow, Wilson, & 
Stanley, 2008).  
Generalized Anxiety Disorder 7-item scale (GAD-7).  GAD-7 is a seven-
item questionnaire that assesses anxiety. Each item is rated 0–3 (0=not at all, 1 = 
several days, 2 = more than half the day, 3 = nearly every day) with scores ranging 
from 0-21. Scores of 5, 10 and 15 are taken as the clinical cut off for mild, moderate 
and severe anxiety respectively. This measure has not been validated in PWD. The 
GAD-7 is commonly used in primary care services (e.g. IAPT). 
Data Analysis 
Statistical Package for Social Sciences (version 24) was used to analyse the 
data. Intention to treat analysis was used, which involves analysing the data of all 
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participants that were randomised, to control for non-compliance and missing data. 
This provides an unbiased estimate of the treatment effect and improves the quality 
and validity of the results (Yelland et al., 2015).  
Due to the small sample size in this study, an exploratory analysis on 
outcomes measures was completed. A Mixed Between-Within Subjects Analysis of 
Variance (ANOVA) was used to compare the outcomes of the MBCT group to 
TAU. All data was checked to see if it met the assumptions of normality and the 
appropriate parametric/non-parametric tests were used. The between subject factors 
was the treatment condition (MBCT group, TAU) and the within subject factor was 
the time (change scores on the CSDD, PHQ-9, RAID and GAD7). Post hoc 
adjustments were not used to control for multiple comparisons because the study 
was underpowered (Kim, 2015).  
Power Analysis 
As this is a feasibility study, it was expected that it would be insufficiently 
powered.  There has been limited high-quality research on the effects of MBCT for 
depression for PWD, which made it challenging to estimate the effect size for this 
study. People with traumatic brain injury (TBI) have similarities with this 
population. Therefore a community based MBCT intervention for TBI with 
depression, which found a significant medium effect size for depression (Bédard et 
al., 2014), was used to estimate the sample size. 
G*Power 3 software was used to calculate the sample size. Based on an A 
Priori analysis, a sample size of 34 was required to detect a medium effect size of 
.25 (Cohen’s f ), when alpha is set at .05 and power at 0.80, for a Mixed Between-
Within Subjects ANOVA.  
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Ethics and Funding 
Ethical approval was granted by City and East Research Ethics Committee in 
London (Ref: 16/LO/0578, Appendix E) and the local Research and Development 
departments (Appendix F). The study was insured by the Joint Research Office at 
University College London (Appendix G). One site obtained funding, from the 
Oxford Mindfulness Centre, to help run the study. 
CONSORT Checklist 
A CONSORT checklist was used to guide the inclusion of information about 
the RCT. This is detailed in Appendix H. 
Results 
Participants 
The CONSORT participant flow diagram is detailed in Figure 1. Twenty 
participants were assessed at baseline (10 MBCT, 10 TAU) and nineteen 
participants at follow up (9 MBCT, 10 TAU). One participant was excluded prior to 
randomisation because physical health difficulties would have prevented her 
attending the MBCT group.  
The mean attendance for both groups was 7.3 (SD=2.63) sessions, with a 
range of two to nine sessions. Eighty percent of participants attended seven or more 
sessions. Two participants dropped out of the MBCT intervention. One participant 
dropped out because of ill health, but completed the follow-up assessment. The other 
participant decided to drop out because she was not enjoying the intervention and 
she did not think she had depression; she did not complete the follow up assessment. 
The last measurement forward technique (LMFT) (Molnar, Hutton, & Fergusson, 
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2008) was used for this participant, which involved the participant’s baseline scores 
being entered as follow up scores; and included in the intention to treat analysis. 
 
Figure 1: CONSORT participant flow diagram  
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Missing Data Analysis 
There was missing data for ten percent (n = 2) of participants on the PHQ-9, 
after using LMFT for another participant. The missing items ranged from one item 
(n = 1, 5%) to nine items (n = 1). Littles’s MCAR test was non-significant (c2 = 
27.22, df = 26, p = .40), which suggests that the PHQ-9 data was missing completely 
at random. The baseline and follow up PHQ-9 data was imputed using Expectation 
Maximization (EM) algorithm. This allowed the data from an extra two participants 
to be used, one at baseline and one at follow up, being included in the analysis for 
PHQ-9. The imputed and non-imputed data is reported. 
Sixty-five percent (n=13) of participants did not have an informant/carer 
available to complete the CSDD and RAID assessment; with reasons including 
living alone with limited family contact or refusing consent to contact a family 
member. Of the available seven carers, there was missing carer data for two 
participants on the CSDD and one participant on the RAID. One carer was 
unavailable to complete the follow up assessment; and there was one missing item 
for the baseline CSDD measure. From the overall sample, there was only 25% (n =  
5) of complete CSDD carer data and 30% (n = 6) complete RAID carer data 
available. Carer data was excluded from the analysis because there was insufficient 
data. 
Descriptive Statistics 
The demographic details of the participants are shown in Table 1. At 
baseline, there were no significant differences between the groups in terms of age, 
ethnicity, marital status, gender, cognitive functioning, depression and anxiety.  
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Analyses 
All data met the assumptions for homogeneity of variance and assumptions 
of normality, required for the ANOVAs. Table 2 shows the mean profiles, mean 
change scores and ANOVA interaction effects for depression and anxiety.  
Exploratory Analyses for Outcome Measures. 
Depression.  At baseline, thirteen participants (seven in intervention group, 
six in control group) were in the clinical range for depression on the CSDD. One 
participant from both groups moved outside the clinical range at post-test. In a 
Mixed Between-Within Subjects ANOVAs, there were no significant interactions 
between time and group found on measures of depression, as assessed by the CSDD 
(F(1,17) = .06, p = .80) and PHQ-9 (F(1,18) = 2.45, p = .14). There was no 
significant main effect of group, as assessed by the CSDD (F(1,17) = 0.54, p = .47) 
and PHQ-9 (F(1,18)= 1.47, p = .24). There was no significant main effect of time, as 
assessed by the CSDD (F(1,17) = 3.60, p = 0.80). However, depressive symptoms, 
as assessed by the PHQ-9, reduced for both the intervention and TAU groups from 
pre-to-post intervention. The significant main effect of time on depressive symptoms 
(PHQ-9) was detected (F(1,18) = 8.68, p = .009), with a very large effect size (  = 
.33)2 (See Table 2). The imputed data for the PHQ-9 was reported. The non-imputed 
data is reported in Table 2 and the results were largely similar. 
Anxiety.  In a Mixed Between-Within Subjects ANOVAs, there were no 
significant interactions between time and group found on measures of anxiety, as 
assessed by the RAID (F(1,17) = .27, p = .61) and GAD-7 (F(1,17) = .69, p = .42). 
There was no significant main effect of group using the RAID (F(1,17) = .18, p = 
.68) and GAD-7 (F(1,17)= .027, p = .87). There was no significant main effect of 
                                                
2 Effect size ( ): small ≥ .01, medium ≥ .06, large ≥ .13 
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time using the RAID (F(1,17) = .04 p = .84) and the GAD-7 (F(1,17) = .83, p = .38) 
(See Table 2). 
Table 1: Demographics 
Characteristics  
Intervention Group 
(n=10) 
Control Group 
(n=10) 
All participants 
(n=20) 
Age (years)      
          Mean (SD) 77.80 (10.63) 76.80 (4.96) 77.30 (8.09) 
          Range  62-93 69-86 62-93 
    
Gender       
          Male (%) 1 (10) 4 (40.0) 5 (25) 
          Female (%) 9 (90) 6 (60.0) 15 (75) 
 
MMSE score 
   
          Mean (SD) 25.50 (3.17) 23.50 (3.50) 24.50 (3.41) 
          Range 21-29 18-28 18-29 
 
Dementia diagnosis 
     
         Alzheimer’s Disease  6  4  10  
         Vascular Dementia  1 2  3  
         Mixed Dementia  1 4  5 
         Dementia unspecified type  2 0 2  
 
Anti-dementia medication  
   
         Prescribed 4 5 9 
         Not-prescribed 3 2 5 
         Unknown 3 3 6 
Average years of formal education (SD)  
11.40 (2.50) 
12.1 (2.52) 11.74 (2.47) 
 
Ethnicity 
   
         White British (%) 8  9  17  
         White European (%) 1  0 1  
         Asian (%) 0 1  1  
         Black Caribbean (%) 1  0 1  
 
Marital status  
   
         Widowed 2 5 7 
         Married 5 5 10 
         Single 1 0 1 
         Divorced 2 0 2 
 
 
 
 
 
		 63	
Table 2: Mean profiles, mean change scores and ANOVA interaction effects for 
CSDD, PHQ-9, RAID and GAD-7. 
Variable n Baseline 
Mean (SD) 
Follow-up 
Mean (SD) 
Change from 
baseline (SD) 
ANOVA 
 
 
 
F 
 
 
df 
 
 
P 
 
 
 
Effect 
Size  
 
CSDD^ 
Treatment  
Control 
 
10 
10 
11.90 (5.38) 
13.6 (4.06) 
10.20 (5.34)            
11.33 (3.64) 
+1.70 (4.42) 
+2.22 (4.57) 
Time 
Group 
TxG 
3.60 
.54 
.06 
1,17 
 
 
.80 
.47 
.80 
.18 
.03 
.004 
PHQ-9 without imputations 
Treatment  
Control 
9                   
9 
14.00 (3.57)            
17.00 (5.36) 
10.67 (4.94)               
11.56 (4.95) 
+3.33 (4.58) 
+5.44 (4.97) 
Time 
Group 
TxG 
15.15 
1.01             
0.88 
1,16 .001*            
.33          
.36 
.49            
.06 
.05 
PHQ-9 with imputations 
Treatment  
Control 
10                   
10 
13.17 (4.26) 
17.3 (5.14) 
11.40 (5.21) 
11.49 (4.67) 
+1.77 (6.56) 
+5.81 (4.84) 
Time 
Group 
TxG 
8.68 
1.47 
2.45 
1,18 .009* 
.24 
.14 
.33 
.08 
.12 
RAID^ 
Treatment  
Control 
10                         
10 
12.1 (5.2)              
14.3 (9.26) 
12.67 (7.62)                
13.0 (7.32) 
-.56 (9.29)                                          
+1.3 (5.96) 
Time 
Group 
TxG 
.044 
.18 
.27 
1,17 .84 
.68 
.61 
.003 
.01 
.02 
GAD-7  
Treatment  
Control 
 
10                            
 10 
8.70 (8.23) 
9.22 (6.28) 
8.60 (6.53) 
7.11 (6.49) 
+.1 (6.38)                         
+1.30 (5.96) 
Time 
Group 
TxG 
.83 
.027 
.69 
1,17 .38 
.87 
.42 
.046 
.002 
.039 
 ( + ) = an improvement, ( - ) = a deterioration, (*) = significance, (^) = only participant data is used 
in the CSDD and RAID. Effect size ( ): small ≥ .01, medium ≥ .06, large ≥ .13. 
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Discussion 
Summary of Results 
Although one measure (PHQ-9) suggested an overall improvement in 
depression over time across both groups, the MBCT group did not show significant 
reductions in depression or anxiety at follow-up, as compared to TAU. Only one 
participant moved outside the clinical range for depression (a measured by the 
CSDD) in both the intervention and control group. Therefore, the null hypotheses 
could not be rejected. The mean change scores may suggest that there were greater 
reductions in depression and anxiety in the TAU group, as compared to the MBCT 
group, although these changes were not significant. This may be explained by 
natural variability, the Hawthorne Effect or it may suggest a problem with the 
MBCT protocol. Also, there were no significant improvements in quality of life and 
cognition (Payne, 2017). 
Interpretations of Findings  
In a feasibility RCT (Churcher Clarke et al., 2017) that tested a mindfulness 
based intervention (MBI) for PWD in care homes, symptoms of depression or 
anxiety were not found to reduce significantly; although a third of the participants 
receiving the intervention moved out of the clinical range of depression. Therefore, 
it was hypothesised that PWD in the clinical range of depression would be receptive 
to treatment (Churcher Clarke et al., 2017), which was not supported in this study. 
However, the mindfulness intervention was more frequent and the duration of 
sessions shorter, with ten hour-long sessions twice weekly (Churcher Clarke et al., 
2017), as compared to eight weekly 90 minute sessions in the protocol used in this 
study. A quasi-experimental study found that an adapted MBSR programme, for 
people with mild cognitive symptoms, significantly improved symptoms of 
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depression (Paller et al., 2015). Eighty percent of these participants had a carer that 
attended the intervention and supported home practice. In contrast, carers did not 
attend the MBCT group in the current study; and only a small proportion of 
participants had a carer or family member (35%) involved in the process. 
Strengths and Limitations 
The feasibility study was underpowered because it was unable to recruit the 
desired number of participants, which increased the likelihood of a type II error. The 
greater mean improvements in the TAU group, as compared to the MBCT group, 
suggests that a greater sample size might have shown that the intervention was 
harmful. However, it is possible that the sample was not representative and another 
random sample may have responded differently, which highlights the importance of 
future studies being sufficiently powered. An alternative explanation is that the 
intervention did not address the needs of this population, such as wider contextual 
issues that impact upon their mental health. 
There were 41 participants assessed for eligibility, however only 21 met 
inclusion criteria. There are several potential reasons for these recruitment 
challenges. The recruitment process relied on clinicians identifying and contacting 
potential participants. This additional work may have reduced their motivation to 
recruit participants. Clinicians may have had difficulties identifying patients with 
mild depression, because older adults may be less inclined to admit depression 
symptoms due to the associated stigma (Overend et al., 2015). In addition, the 
inclusion criteria may have been too narrow. 
Adherence to the adapted MBCT protocol was not formally measured, 
although it was assumed to be poor because there was insufficient time to complete 
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all the tasks in each session. This was a consequence of not field-testing the 
intervention. The session content was prioritised by informal discussions with the 
facilitators and the MBCT supervisor. The validity and reliability of estimating 
treatment fidelity would be improved using a standardised adherence tool, such as 
the MBCT assessment scale (Prowse, Nagel, & Meadows, 2015). 
The evidence base suggests that home practice is a key component of 
mindfulness based interventions (Segal et al., 2002); with more formal home 
practices, such as meditations guided by an audio CD, being associated with greater 
improvement on depression measures (Crane et al., 2014; Hawley et al., 2014; 
Perich, Manicavasagar, Mitchell, & Ball, 2013). Cognitive impairments in this 
population may have meant that participants did not remember to do home practice; 
and there was a large proportion of the participants that did not have a carer 
available to support them. Therefore, the lack of support may have undermined the 
effectiveness of the intervention. Qualitative feedback from facilitators suggests that 
just three participants regularly completed formal home practices.  
The CSDD and RAID involved interviewing PWD and an informant/carer. 
As a large proportion of participants did not have an available informant/carer to 
provide collateral information, the results are based on the participant data on the 
CSDD and RAID, which may have compromised the validity of the measures. It 
appeared that participants could make an informed evaluation on their mood and 
anxiety, as they only had mild cognitive impairment. Therefore, measures that rely 
on collateral information from carers may not be the most appropriate measures for 
people with mild dementia living in the community. Future research in this 
population should use validated outcome measures that do not rely heavily on 
collateral information from an informant/carer, such as the Montgomery-Asberg 
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Depression Rating Scale (Montgomery & Asberg, 2006). The validity of measures 
may be reduced by a lack of collateral information, although it would facilitate 
depression research for people with mild dementia that do not have an available 
carer. 
There were several variables that had insufficient data to report, such as the 
use of anti-depressant medication, pre-morbid depression and time since diagnosis. 
This information should be collected consistently in future research. 
Implications in Care Practice and Future Research 
There is inadequate evidence to recommend this adapted MBCT intervention 
for PWD in memory clinics. The MBCT intervention needs redevelopment and 
piloting before further testing in an RCT. It is recommended that evidenced based 
mindfulness interventions are field tested in this population before making 
assumptions about suitable adaptations, such as the original MBCT (Segal et al., 
2002) and MBSR (Kabat-Zinn, 2013) programmes or the MBI protocol for PWD in 
care homes (Churcher Clarke et al., 2017). A case series design may help with the 
development of the intervention and the selection of the most appropriate outcome 
measures for depression and anxiety.  
Future research on MBIs should provide participants with an audio player 
that records the number of hours of formal home practice (e.g. listening to CD 
tracks). MBCT protocols should also consider way of supporting home practice for 
PWD that do not have the support of carers. Participant rating forms would be 
beneficial to identify the participants preferences for exercises, which has been used 
in previous mindfulness research (Churcher Clarke et al., 2017). Qualitative research 
is currently being done by an MSc Student, which will inform the development of 
future interventions. 
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Conclusion 
 This feasibility RCT found that an adapted MBCT group intervention, for 
PWD who were depressed, did not lead to changes to depression or anxiety, as 
compared to TAU. This may be the result of the study being insufficiently powered 
or it may suggest a problem with the intervention. The MBCT protocol will need to 
be redeveloped and field-tested with PWD. 
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Introduction 
In the critical appraisal, I will reflect on conducting the empirical study and 
my experience of facilitating a Mindfulness Based Cognitive Therapy (MBCT) 
group. Firstly, I will discuss how my background influenced my choice of research. 
Secondly, I will discuss the recruitment challenges and my experiences of 
facilitating the adapted MBCT group. Finally, I will consider the findings from the 
empirical paper, based on my experience of facilitating the group and the 
discussions I had with participants and carers.  
My Background 
Prior to starting the Doctorate in Clinical Psychology, I worked as an 
Assistant Psychologist (AP) in a memory clinic. Through my clinical practice, I 
noticed a lack of evidenced based treatments for psychological difficulties, such as 
depression and anxiety, in people with dementia (PWD). This informed my 
literature review and empirical paper. The literature review found that certain 
psychosocial interventions are effective at reducing symptoms of depression and 
anxiety in PWD who are depressed or anxious. Most of the studies that tested 
intervention for depression recruited PWD, with mild to moderate cognitive 
impairment, residing in nursing homes. This suggested that further research was 
required to test psychosocial interventions, for PWD with depression, in the 
community. The empirical paper tested an MBCT intervention for depression in 
PWD attending memory clinics. 
Recruitment Challenges 
There were unexpected challenges that led to delays in starting the MBCT 
group. We obtained ethical approval four month later than expected, which resulted 
in delays completing eligibility assessments and starting the groups. We relied on 
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clinicians to identify and contact potential participants, which added to their 
workload and potentially reduced their motivation to recruit. Clinicians were also 
under pressure to reduce waiting times, in line with the Prime Minister’s Challenge 
on Dementia (Department of Health, 2015). In addition, memory clinics focus on the 
cause and treatment of memory impairments and there appeared to be limited scope 
to assess psychological difficulties such as symptoms of depression. Only a small 
proportion of men were referred to the group and I was curious about the reasons for 
this.  
Older adults, especially men, may have been reluctant to admit that they were 
experiencing depressive symptoms, due to the associated stigma (Overend et al., 
2015). There may also have been a stigma about asking for help in general. It would 
have been useful if the service used a routine outcome measure to identify those 
with depression. The team managers reported that they tended to refer PWD with 
psychological difficulties to third sector organisations (e.g. charities). Therefore, if I 
were to do research in this population again, I would recruit participants from a 
range of services, such as General Practitioners (GP), third sector organisations and 
memory clinics.  
Participants were recruited in memory clinics from two trusts, named Site 
One and Site Two. Each site brought with them recruitment challenges. In Site One, 
we recruited 12 participants in four months and started running the MBCT group in 
September 2016. We were going to postpone the group until January 2017 to enable 
further recruitment; however, we were unable to do this because the second 
facilitator was due to retire. Recruitment may have been somewhat easier in Site 
One because I had worked there as an AP, and I had built good relationships with 
the management team. The team managers incorporated short mindfulness 
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meditations at the end of team meetings, which helped clinicians appreciate the 
benefits of mindfulness and encourage them to refer. Site One also had a free 
training route for clinicians that wanted to become MBCT practitioners; therefore, 
there was an appreciation and value to using MBCT. 
Recruitment was particularly difficult in Site Two. There were several 
research studies that were running simultaneously, which may have contributed to 
research fatigue in the memory clinic staff. In addition, it appeared that staff did not 
see the value in mindfulness. We speculated that clinicians were struggling to retain 
the information about the different studies, which in turn limited their ability to refer 
people to the group. Therefore, the MBCT group was delayed until January 2017. 
Despite seven months of recruitment, there were only nine participants recruited 
from this site.  
Facilitating the MBCT Group 
 I was one of the facilitators, for the MBCT intervention, in Site One. I 
completed an MBCT course and I continued my mindfulness practice prior to and 
during the group. However, I had not completed the MBCT teacher training. I 
facilitated the group with an internal member of staff (BM). He was an art therapist 
who practiced meditation for several decades and had recently qualified as a Level 
One trained MBCT practitioner. Due to BM’s experience of using mindfulness, he 
facilitated most of the meditations and enquiries. However, I facilitated Cognitive 
Behavioural Therapy (CBT) exercises because I had more experience in this area. I 
found it difficult to facilitate the enquiry for mindfulness practices and this is likely 
due to my lack of experience. Therefore, I agree with the literature that suggests that 
MBCT facilitators are required to partake in their own mindfulness meditation 
practice (Segal, Williams, & Teasdale, 2002), to ensure the integrity of the MBCT 
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intervention (Crane et al., 2014). As this was our first experience of running an 
MBCT group, the guidance we received from our supervisor, an Oxford 
Mindfulness Centre facilitator, was essential.  
Findings of Empirical Paper 
The MBCT group did not show significant improvements in depression and 
anxiety, as compared to treatment as usual (TAU). The TAU group presented with 
greater improvements, as compared to the treatment group. I was surprised about 
these results because the mean attendance was high (7.3 sessions), attrition was low 
(10%) and the qualitative feedback was positive, which suggested that the MBCT 
intervention had a high level of acceptability. These findings maybe the result of 
natural variability. However, it may indicate that there were wider issues that needed 
to be addressed. To make sense of these findings, I reflected on my experiences of 
running the group and the discussions I had with participants and carers in Site One. 
These discussions took place during the group or during phone calls in between 
sessions. 
MBCT Protocol 
Practical Issues with the Protocol.  The MBCT protocol was not field 
tested therefore several problems emerged. There was too much material to be 
covered in the allocated time. This meant that either the sessions were rushed or 
some of the material was not delivered. Therefore, it is unlikely that both groups got 
exactly the same intervention. The session content was prioritised by informal 
discussions with the facilitators and the MBCT supervisor. To improve treatment 
fidelity, a standardised adherence tool should be used to monitor adherence. 
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Participants’ Response to Mindfulness.  The group had a mixed response 
to mindfulness. The participant that dropped out of the group, after session two, said 
that the mindfulness exercises were ‘weird’ and ‘cult-like’. One participant said that 
he did not believe in the benefits of mindfulness. However, he admitted that he 
found the group relaxing and he started using deep breathing, outside the group, to 
help him calm down when he was angry. Another participant said that she preferred 
a Cognitive Stimulation Therapy (CST) group that she attended because it involved 
doing fun activities. She said that she enjoyed doing the mindfulness exercises in a 
group environment because it was relaxing and it generated discussion. However, 
she did not see the benefits of doing these exercises at home because she found it 
less enjoyable and harder to concentrate. Likewise, one participant appreciated 
doing the mindfulness exercises in the group but she disliked listening to the CD. 
She said she enjoyed the questions that were asked after the mindfulness exercise 
[the enquiry] because she felt positive about being able to participate in the 
discussion. A similar finding, about the importance of being able to participate in 
discussions, has been reported in other groups for PWD (Spector et al., 2011). In 
contrast, one participant preferred listening to the CD. There were two reasons for 
this; firstly, her hearing aid broke after the second session therefore she had 
difficulty hearing the exercises, despite sitting next to the facilitators. Secondly, the 
exercises provided structure to her day because she would complete the exercises 
before getting up in the morning, before lunch and before going to bed. She reported 
that this benefited her mood. 
Specific Exercises. Dementia is associated with difficulties with abstract 
thinking (Amieva, 2005); thus, it understandable that participants had difficulties 
with the more abstract exercises, such as the ‘raison exercise’ and the story about 
		 84	
‘the king and his three sons’. It was evident that the participants found the ‘raison 
exercise’ confusing and they became distracted by what other participants were 
doing. Also, the exercise called ‘the king and his three sons’ represents the 
disadvantages of pushing away your problems. The group had difficulties inferring 
this meaning from this story. Instead the story evoked feelings of rejection from 
their childhood. These exercises either need to be removed or adapted for this 
population. The group appeared to prefer the more concrete mindfulness exercises 
such as mindful listening, mindful stretching and grounding exercises.  
The mindful walking exercise was not appropriate for the participants in Site 
one due to mobility issues, therefore it may need to be adapted for future groups. We 
tried to limit mindfulness exercises to ten minutes because participants started to 
lose their concentration after this time. There were two occasions when the exercises 
were approximately 15 minutes long and it was noticed that the participants were 
becoming restless. Future research should use participant rating forms to identify the 
participants preferences for exercises, which has been used in previous mindfulness 
research (Churcher Clarke et al., 2017). 
A poem, that was connected to the theme of the session, was read at the end 
of every session. However, some participants had difficulties with their working 
memory and abstract thinking, which impaired their ability to infer meaning from 
the poem. I included the poem in their homework packs to allow them to read it at 
home. However, the poetry did not appear to add anything beneficial to the 
intervention. On reflection, we should have consulted with service users before 
using the poems in the sessions. 
There will be challenges associated with developing an MBCT protocol for 
PWD because it needs to cater for various combinations of physical and cognitive 
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impairments. I think that the facilitators should have experiences of working with 
PWD, because they will have experience of adapting to the needs of each group. 
Home Practice.  Home practice, a key component of mindfulness based 
interventions (Segal et al., 2002) involved ‘formal’ practices (listening to the audio 
recording of mindfulness exercises) and ‘informal’ practices (incorporating 
mindfulness into routine daily experiences, such as eating, walking and brushing 
teeth). Participants were asked to complete formal practice five times a week; and 
informal practice for an additional 10–15 minutes a day. Each participant was 
provided with a folder that detailed the content of each session and the home 
practice they needed to complete. The feedback from participants and carers, was 
that they did not use the folder in between sessions because the content was difficult 
to understand. In addition, there was one participant that was unable to read. These 
folders need to be reconsidered in future groups. 
In MBCT, participants are asked to reflect on their home practice at the 
beginning of each session (Segal et al., 2002). In my experience of running the 
group, it was very difficult for participants to reflect on their home practice. This 
was partly due to participants not doing the home practice or not remembering the 
home practice they completed. Therefore, we decided that it was more beneficial to 
reflect on the mindfulness practices done in the sessions. In addition, participants 
were more likely to complete the formal practices, as opposed to the informal 
practices. I think the participants struggled to understand the informal practices 
because of their abstract nature. Therefore, I think there should be a greater 
emphasis on the formal practice, as opposed to informal practice, to support 
understanding, which is also indicated in the literature (Crane et al., 2014; Hawley et 
al., 2014; Perich, Manicavasagar, Mitchell, & Ball, 2013). In my opinion, home 
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practice needs to be simplified and it may be more beneficial to have one or two 
core meditations that carry across the sessions. 
Support with Home Practice.  I believe that the participants would have needed 
support to do home practice. The majority of participants did not have a carer to 
support them, which is not uncommon in this population. Therefore, interventions 
for depression need to be developed for PWD that do not have the support of a carer.  
The carers, that were available for two participants in site one, reported that 
they were not sure how to provide support because they did not have a clear 
understanding of mindfulness. These carers attended a psycho-education session 
about the format of the mindfulness sessions, which also involved doing some brief 
mindfulness exercises. It was noticed that they were not participating in these 
exercises. I was not able to discuss the reasons why they did not participate, but it 
may have been due to embarrassment. The carers may need more preparation for 
this session. Also, it might be beneficial to also provide carers with the mindfulness 
intervention. I think it would be best to have a separate group for carers because the 
PWD said that they appreciated having their own space; for instance, one participant 
reported that they became frustrated when her husband would talk on her behalf. 
We rang participants in between sessions to see if they had any questions 
about their mindfulness practice. This aimed to act as a reminder for participants to 
do their home practice. This call was appreciated in Site One and I think that it 
helped with the engagement of participants and reduced potential dropouts. 
However, Site Two reported that the mid-week call confused participants and they 
stopped doing it after several weeks. I speculated that participants in Site One were 
more isolated therefore they appreciated the mid-week call more than those in Site 
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Two. Therefore, the benefits of a mid-week call may need to be discussed further in 
service user consultations. 
Group Experience  
A Sense of Belonging.  The participants reported that they enjoyed taking 
part in the group and they looked forward to meeting every week. The group bonded 
over their shared experience of having mild dementia and symptoms of depression. 
It was reported that this provided them with a sense of belonging because they felt 
that the group understood the difficulties they were going through. The group said 
that they appreciated the opportunity to share their experiences and frustrations. In a 
qualitative study, people with mild Alzheimer’s reported that they value sharing 
their experiences and receiving support from other people experiencing similar 
difficulties (Sørensen, Waldorff, & Waldemar, 2008).  
Two participants discussed their experiences of other groups for PWD. They 
shared that they did not enjoy groups that catered for all severities of dementia 
(mild, moderate, severe), because they did not identify with people with more severe 
dementia. This made me reflect that services may label people with dementia, 
without thinking about the differing needs at different stage of the disease. This 
suggests that there needs to be a range of interventions for different severities. 
Participants also reported that they enjoyed listening to the other people’s 
struggles and providing advice if required. For instance, some participants shared 
memory strategies with each other and one participant said that it felt good to be 
able to help others. The value of listening to others has also been identified by PWD 
attending a Cognitive Stimulation Therapy group (CST; Spector, Gardner, & Orrell, 
2011). Participants said that they were disappointed that the group was only for nine 
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weeks and they wished the group was continuing, which has been reported in other 
time-limited groups for PWD (Spector et al., 2011).   
I speculate that the progress made during the group may have been 
underestimated because some of the follow-up assessments were completed two 
weeks after the intervention. The participants reported negative feelings about the 
loss of social contact from the group, which may have increased their depression and 
anxiety scores. To understand changes throughout the intervention, we intended to 
collect outcome measures (PHQ-9 and GAD-7) after every session. This was not 
possible due to time-constraints, because each participant needed support 
completing each questionnaire. On reflection, it may have more appropriate to 
complete these questionnaires during the phone call in between sessions. 
Isolation and Inactivity.  Participants explicitly spoke about isolation and 
the limited resources available to them. They spoke about wanting more social 
groups to meet people, which they suggested would improve their mood. This is 
consistent with a qualitative study for PWD that suggested that nursing home 
residents preferred interventions that reduced isolation, as opposed to group or 
individual psychotherapy (Choi, Ransom, & Wyllie, 2008). Some participants 
discussed that the group gave them a purpose to get up in the morning. They 
reported that dementia had prevented them doing activities that used to give them 
pleasure (e.g. working, driving, visiting people) and they did not know what they 
could do instead. 
Reflection on Group Experience.  The group provided participants with 
mindfulness strategies to cope with symptoms of depression. In my opinion, this was 
merely hiding the larger socio-political issues; such as the reduction of charity sector 
services and the limited resources in the National Health Service (NHS). I believe 
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that interventions to reduce isolation are a priority in this population. I was curious if 
participants were attending the group for the social interaction or for the MBCT 
intervention. Therefore, if I were to test a group intervention in this population 
again, I would compare it with another group intervention for example, a 
conversation group. 
Conclusion 
The empirical paper has provided me with a clearer understanding of the processes 
required to produce good quality research. This experience has taught me about the 
challenges of recruiting patients in the NHS and the importance of good 
relationships to facilitate this process. I have learned that new interventions require a 
robust development phase with service user consultation. I also started my journey 
to become a mindfulness practitioner and I have become aware of the importance of 
developing my own regular mindfulness practice. I have learned some of the 
complexities of doing research with people with mild dementia, such as the lack of 
carer involvement and the wider contextual issues that impact upon their mental 
health.  
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Database Cognitive impairment 
filter 
Depression or anxiety filter Psychosocial intervention filter Randomised 
trial filter 
Psychinfo dementia.ti,ab OR cog* 
impair*.ti,ab OR mild 
cog*.ti,ab OR 
Alzheimer*.ti,ab OR 
'vascular dementia'.ti,ab OR 
frontotemporal.ti,ab OR 
pick* dis*.ti,ab OR multi 
infarct.ti,ab OR 
((cognit* or memory) adj3 (
declin* or impair* or los* or
 deteriorat* or degenerat* or
 complain* or disturb* 
or disorder*)).ti,ab  
 
depress*.ti,ab 
OR dysthymi*.ti,ab OR 
adjustment disorder*.ti,ab OR 
mood disorder*.ti,ab OR 
mood.ti,ab OR 
affective disorder*.ti,ab OR 
affective symptom*.ti,ab 
OR anxiety.ti,ab 
OR anxious.ti,ab OR 
overanx*.ti,ab OR anxiety 
disorder.ti,ab OR anx*.ti,ab 
OR acute stress disorder.ti,ab 
OR general* anxiety 
disorder.ti,ab OR panic 
disorder.ti,ab OR panic 
attack*.ti,ab OR post 
traumatic stress disorder.ti,ab 
OR obsessive compulsive 
disorder.ti,ab OR 
?phobi*.ti,ab OR 
panic disorder.ti,ab  
 
psychotherap*.ti,ab 
OR psychosocial*.ti,ab 
OR psychoeducational.ti,ab OR 
behavio$r therapy.ti,ab OR 
intervention.ti,ab OR 
counselling.ti,ab OR 
counsel*.ti,ab OR cognitive 
therapy.ti,ab OR CBT.ti,ab OR 
family therapy.ti,ab OR stress 
management.ti,ab OR coping 
skill*.ti,ab OR social support.ti,ab 
OR relaxation techniques.ti,ab 
OR music .ti,ab OR exercise.ti,ab 
OR doll therapy.ti,ab 
OR reminiscence.ti,ab OR foot 
massage.ti,ab OR Sonas.ti,ab OR 
aerobic*.ti,ab OR exercise.ti,ab 
OR Mindful*.ti,ab OR 
MBCT.ti,ab OR MBSR.ti,ab OR 
group.ti,ab 
"double-blind" 
OR "random* 
assigned" OR 
control OR 
randomi?ed 
controlled 
trial.pt 
Embase dementia.ti,ab OR cog* 
impair*.ti,ab OR mild 
cog*.ti,ab OR 
Alzheimer*.ti,ab OR 
'vascular dementia'.ti,ab OR 
frontotemporal.ti,ab OR 
pick* dis*.ti,ab OR multi 
infarct.ti,ab OR 
((cognit* or memory) adj3 (
declin* or impair* or los* or
 deteriorat* or degenerat* or
 complain* or disturb* 
or disorder*)).ti,ab  
 
depress*.ti,ab 
OR dysthymi*.ti,ab OR 
adjustment disorder*.ti,ab OR 
mood disorder*.ti,ab OR 
mood.ti,ab OR 
affective disorder*.ti,ab OR 
affective symptom*.ti,ab 
OR anxiety.ti,ab 
OR anxious.ti,ab OR 
overanx*.ti,ab OR anxiety 
disorder.ti,ab OR anx*.ti,ab 
OR acute stress disorder.ti,ab 
OR general* anxiety 
disorder.ti,ab OR panic 
disorder.ti,ab OR panic 
attack*.ti,ab OR post 
traumatic stress disorder.ti,ab 
OR obsessive compulsive 
disorder.ti,ab OR 
?phobi*.ti,ab OR 
panic disorder.ti,ab  
 
psychotherap*.ti,ab 
OR psychosocial*.ti,ab OR 
OR psychoeducational.ti,ab OR 
behavio$r therapy.ti,ab OR 
intervention.ti,ab OR 
counselling.ti,ab OR 
counsel*.ti,ab OR cognitive 
therapy.ti,ab OR CBT.ti,ab OR 
family therapy.ti,ab OR stress 
management.ti,ab OR coping 
skill*.ti,ab OR social support.ti,ab 
OR relaxation techniques.ti,ab 
OR music .ti,ab OR exercise.ti,ab 
OR doll therapy.ti,ab 
OR reminiscence.ti,ab OR foot 
massage.ti,ab OR Sonas.ti,ab OR 
aerobic*.ti,ab OR exercise.ti,ab 
OR Mindful*.ti,ab OR 
MBCT.ti,ab OR MBSR.ti,ab OR 
group.ti,ab 
random$ OR 
factorial$ OR 
crossover$ OR 
cross over$ OR 
cross-over$ OR 
placebo$ OR 
doubl$ adj 
blind$ OR 
singl$ adj 
blind$ OR 
assign$ OR 
allocat$ 
 
Ovid 
Medline 
dementia.ti,ab OR cog* 
impair*.ti,ab OR mild 
cog*.ti,ab OR 
Alzheimer*.ti,ab OR 
'vascular dementia'.ti,ab OR 
frontotemporal.ti,ab OR 
pick* dis*.ti,ab OR multi 
infarct.ti,ab OR 
((cognit* or memory) adj3 (
declin* or impair* or los* or
 deteriorat* or degenerat* or
 complain* or disturb* 
depress*.ti,ab 
OR dysthymi*.ti,ab OR 
adjustment disorder*.ti,ab OR 
mood disorder*.ti,ab OR 
mood.ti,ab OR 
affective disorder*.ti,ab OR 
affective symptom*.ti,ab 
OR anxiety.ti,ab 
OR anxious.ti,ab OR 
overanx*.ti,ab OR anxiety 
disorder.ti,ab OR anx*.ti,ab 
OR acute stress disorder.ti,ab 
psychotherap*.ti,ab 
OR psychosocial*.ti,ab OR 
OR psychoeducational.ti,ab OR 
behavio$r therapy.ti,ab OR 
intervention.ti,ab OR 
counselling.ti,ab OR 
counsel*.ti,ab OR cognitive 
therapy.ti,ab OR CBT.ti,ab OR 
family therapy.ti,ab OR stress 
management.ti,ab OR coping 
skill*.ti,ab OR social support.ti,ab 
OR relaxation techniques.ti,ab 
(randomi?ed 
controlled trial 
OR controlled 
clinical trial OR 
randomi?ed .ti,a
b OR 
placebo.ti,ab 
OR clinical 
trials as topic 
OR 
randomly.ti,ab 
OR trial) 
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or disorder*)).ti,ab  
 
OR general* anxiety 
disorder.ti,ab OR panic 
disorder.ti,ab OR panic 
attack*.ti,ab OR post 
traumatic stress disorder.ti,ab 
OR obsessive compulsive 
disorder.ti,ab OR 
?phobi*.ti,ab OR 
panic disorder.ti,ab  
 
OR music .ti,ab OR exercise.ti,ab 
OR doll therapy.ti,ab 
OR reminiscence.ti,ab OR foot 
massage.ti,ab OR Sonas.ti,ab OR 
aerobic*.ti,ab OR exercise.ti,ab 
OR Mindful*.ti,ab OR 
MBCT.ti,ab OR MBSR.ti,ab OR 
group.ti,ab 
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Appendix B: Session Plans 
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Session 1: Awareness and Automatic Pilot 
FOFBOC – on arrival – use as grounding practice.  
Ground rules  
Overview of Course  
Expectations: ask group members to briefly share expectations. ‘’what would you like to take away 
from the course’’. 
PRACTISE 1: Raisin Exercise  
PRACTISE: ‘taking your seat’ followed by 10 minute Body scan using similar language to CD.  
Rationale: see handout ‘learning that comes from body scan’. Keep simple and short for this group as 
too much too soon could cause aversive reaction. Issues re: attention/concentration also need to be 
considered.  
Feedback and Enquiry 
Reflection on Theme: Connecting practice to session theme. Overview of automatic pilot.   
Home Practice: discuss and consider barriers and challenges to undertaking practice.  
Formal: brief body scan (CD 1 -track 1), Mindfulness of a routine activity  
Habit releaser – spend a moment reflecting on something you might do differently.  
One Mindful moment or one mindful mouthful. 
Review/session summary 
Breath focus – one minute breathing space leading into poem – ‘If I had my life to live over’  
 
Session 2: Living in Our Head 
Grounding Practice 
Recap material from week one 
PRACTISE 1: Body Scan – See facilitators guide: the process of Inquiry 
Home practice Review : See facilitators guide: the process of Inquiry   
Teaching/ACTIVITY : Thoughts and feeling exercise:  
“You’re walking down the street and coming toward you, on the other side of the street you see 
someone you know. You smile and wave but the person doesn’t seem to notice and walks on by. 
What thoughts pop into your head? What emotions and what body sensations?” (draw on relationship 
between situation, thoughts, feelings). 
See script and outline for details on feedback. 
Reflection on Theme: Connecting practice to session theme.  
Practice: the body scan helps reveal the doing mode: the body holds and expresses emotions. We can 
feel through our body, the body reacts to the mind it also feedbacks to the brain which can fuel our 
worries fears etc.  
PRACTISE: 10 minute sitting – The Breath  
Handout: distribute handouts. Review contents briefly.  
Home Practice: Discuss and consider barriers and challenges to undertaking practice.  
Formal: brief body scan, Mindfulness of a routine activity. 
Pleasant experiences Calendar- only one example daily) 
Habit releaser – (check who does this already and if so remember to add a habit releasing instruction) 
going for a walk (instruction: stress releaser, mood booster intentionally– pay attention to the detail. 
Stop and look around, walk a new path, explore something different, is this different way of ‘walking 
than you would normally do?).  
One Mindful moment (Pause to Appreciate) or one mindful mouthful.  
Review/session summary  
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Session 3: Gathering The Scattered Mind 
Grounding practice: Five-minute seeing (or hearing) exercises 
Recap material from week two and introduce theme of week three 
PRACTISE: 2 Three step breathing space and review. 
PRACTISE: 3 Mindful Stretching  
Teaching - Reflection on Theme: The Scattered Mind 
Reflection on Theme: Connecting practice to session theme.  
Practice: the body scan helps reveal the doing mode: the body holds and expresses emotions. We 
can feel through our body, the body reacts to the mind it also feedbacks to the brain which can fuel 
our worries fears etc.  
Handout: distribute handouts. Review contents briefly.  
Home Practice: Discuss and consider barriers and challenges to undertaking practice.  
Formal: mindful movement meditation followed by Breath a body meditation  
Unpleasant experiences calendar - a different experience each day;  
three-step breathing space three times daily 
Mindfulness of a routine activity – different to previous week. 
Habit releaser – valuing your entertainment – rather than doing it as you usually would. See 
instruction sheet.  
One Mindful moment or one mindful mouthful. 
Review/session summary  
Breath focus – one minute breathing space leading into poem: The breath or the river bank 
 
Session 4: Recognising Aversion 
Grounding exercise: Five-minute seeing or hearing exercise.  
SCAFFOLD/RECAP: summary /key points poster or power point from session 3. 
PRACTISE 1: 15 minutes meditation – awareness of breath and body  
Following seamlessly into reading a poem such as wild geese  
See facilitators guide: the process of Inquiry  
Home practice Review: See facilitators guide: the process of Inquiry   
Reflection on Theme: Connecting practice to session theme – recognizing aversion  
Defining the territory of depression and the role of automatic thoughts. Beginning the process of 
naming, understanding ‘’symptoms’’ and the way they manifest.  
Brief reflection on depression criteria (although not likely to be as helpful with our group but use 
judgement and be creative) ask the group: What does this tell us? What do you notice or see? 
Some reflection on ‘DEMENTIA’ is possibly also required here – how their response may be 
linked to their diagnosis, the existential issues and the uncertainty that it brings.  
PRACTISE: Mindful walking - See facilitators guide: the process of Inquiry   
Home Practice:  
Formal: – breath and body meditation and sounds and thought meditation. 
Three step breathing space- regular (three times a day) 
Three step breathing space – responsive (whenever you notice unpleasant feelings). (track 8) 
Mindfulness of a routine activity – different to previous week. 
Habit releaser – pop out at a set time of day but without planning the activity itself. See what takes 
your fancy. People with dementia might struggle with this so may require adapting further 
depending on group.  
One Mindful moment or one mindful mouthful. 
Review/session summary:  
Three step breathing space. leading into poem – just for now by Danna Faulds 
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Session 5: Allowing and Letting be  
 
 
Session 6: Thoughts are not facts  
Grounding practice - Short standing Meditation (mountain) 
PRACTISE 1: Sitting meditation: See facilitators guide: the process of Inquiry   
Home practice review: See facilitators guide: the process of Inquiry 
ACTIVITY: see facilitators notes for instructions:  
John was on his way to school, He was worried about the math lesson, He was not sure he could 
control the class again today. It is not part of a janitors duty. Lead onto FACT or Fiction exercise.  
Reflection on Theme: Connecting practice to session theme.  
When you suffer from depression or anxiety the associated thoughts have ‘psychological’, 
‘biological’ and ‘social’ consequences. Exercise: think with the group about the different levels of 
impact of these thoughts. See week 6 activities sheet.   
PRACTISE: The befriending meditation. See facilitators guide: the process of Inquiry 
Start thinking with the group about preparation for the end of the course. Brief discussion. ‘’what 
will you put in your tool box?’’ use Tool box worksheet to start list making: working wisely, 
treading lightly: my tool box (name can be changed to suit group.  
Here we are not doing the usual relapse signature/prevention work. Linking to idea of ‘keeping 
well’.  
Handout: distribute handouts. Review contents briefly.  
Home Practice: 
Formal: Befriending Meditation (track 7, 10 minutes), 6 out of 7 days. Aim to sit quietly for a few 
minutes before you do this meditation or use tracks 1 or 4 from the CD to help you. Three minute 
breathing space (responsive as you need it). 
Mindfulness of a routine activity – different to previous week. 
Habit releaser – spend a moment reflecting on something you might do differently. Random act of 
kindness.  
One Mindful moment or one mindful mouthful. 
PRACTICE: Breathing space and review. - Discuss breathing space as the first step before taking a 
wider view of thoughts.  
Review/session summary: What will you take away from today? Parachute (group and individual). 
 
 
 
Grounding practice - Short standing Meditation 
SCAFFOLD/RECAP: Summarise session 4 and introduce the session theme for week 5. 
PRACTISE 1: 10 minutes sitting practice awareness of breath body and thoughts 
Home practice Review 
Story of the King and his three Son’s (see script and guidance on reflection)  
Reflection on Theme: Connecting practice to session theme.  
Some reflection on ‘DEMENTIA’ again is possibly also required here 
Reading Rumi’s poem The Guest house 
PRACTISE: Breathing space extended. See facilitators guide: the process of Inquiry   
Handout: distribute handouts. Review contents briefly.  
Home Practice: breath and body meditation,three step breathing space- regular and responsive 
Mindfulness of a routine activity, habit releaser, habit releaser  
Review/session summary:  
Breath focus – one minute breathing space leading into poem ‘reply to Rumi’ 
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Session 7: How Best to Take Care of Myself  
Grounding practice - Short standing Meditation  
SCAFFOLD/RECAP: Summarise session week 6 and introduce theme for session 7 
PRACTISE 1: befriending meditation. See facilitators guide: the process of Inquiry 
Home practice review 
PRACTISE 2: Guided meditation Mountain (resilience). See facilitators guide: the process of 
Inquiry 
ACTIVITY – rebalancing your life: Nourishing and depleting exercise (see guide) 
Generating list of pleasure and mastery activities (see guide) 
Reflection on Theme: Connecting practice to session theme. Mindfulness, Resilience and 
compassion. What do we need to maintain well-being. ‘’How to best take care of myself when 
depression threatens to overwhelm me?’’Activity: get participants to brainstorm  
Poem: if you would grow 
Planning for the future: Exercise to explore links between activity and mood plan how best to 
schedule activities for when mood threatens to overwhelm. Consider an action plan. Identifying 
actions to deal with the threat of recurrence. What I will do? Handout template: My 
Manifesto/my pledge worksheet: How to keep well. How to take care. What to look out for. 
Spend some time working through this. See guidance.  
Handout: distribute handouts. Review contents briefly.  
Home Practice: discuss and consider barriers and challenges to undertaking practice.  
Formal: choosing a selection of favoured practices this week 1 or 2 a day. 
Mindfulness of a routine activity – different to previous week. 
Habit releaser – spend a moment reflecting on something you might do differently. 
One Mindful moment or one mindful mouthful. 
Review/session summary:  
Breath focus – one minute breathing space leading into poem – Summers Day (Mary Oliver) 
 
Session 8: Maintaining and Extending New Learning 
Grounding practice body focused practice coming full circle  
SCAFFOLD/RECAP: Summarise week 7 and introduce theme for week 8. 
PRACTISE: body focused meditation 
Home practice review and general discussion and reflections on role of practice. How to take 
this forward and what to do with the struggle. 
REVIEW OF Expectations: ask group members to briefly share expectations. ‘’what would you 
likely to take away from the course’’. Note on flip chart and keep for review towards end of 
course. Expectations of participants - commitment to group. Importance of home practice.  
Reflection on Theme. Summary of course.  
BREAK 
Handout: distribute handouts. Review contents briefly.  
Review/session summary: What will you take away from the course? – review tree of life. 
‘’Endings’’ ‘’taking this forward’’ 
Maybe sit or stand in circle. Opportunity to give something to rest of group. Gift in form of 
word or something that allows a nice ending.  
Closing sentiments – what I would like to give is… 
Handout tokens  
Breath focus – one minute breathing space leading into poem 
‘A Slow Dance’ - Anon  
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Task  Contributor 
Design of the research study DN and JP 
Ethics DN and JP 
Attending team meetings DN and JP 
Recruitment DN (Memory Clinic 1) JP (Memory Clinic 2) 
Contacting clients for assessments  DN (Memory Clinic 1) JP (Memory Clinic 2) 
Booking transport  Deirdre (Memory Clinic 1), research manager at 
site two (Memory Clinic 2) 
Assessments  Deirdre, Jacob, PhD Student, research assistant 
Making packs/CDs for the group  Deirdre and research assistant 
Group sessions  Deirdre and Facilitator from site two 
Mid-week call from group facilitators  Deirdre and research manager at site two 
Data entry  DN and JP 
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Appendix D1: Participant Information Sheet 
RESEARCH DEPARTMENT OF CLINICAL, EDUCATIONAL AND HEALTH 
PSYCHOLOGY 
 
 
 
PARTICIPANT INFORMATION SHEET 
Study Title: A Mindfulness-Based Cognitive Therapy (MBCT) Group for People 
with Memory Problems and Low Mood (Student Research Project) 
Invitation to participate in a research study 
You are being invited to take part in a research study. Before you decide, it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Thank you for reading this information sheet. 
What is the purpose of the study? 
This study aims to find out whether mindfulness training can help improve the 
mood, anxiety and quality of life of people experiencing memory problems and low 
mood. 
Who is organising and funding the research? 
The research is being organised by University College London and funded by the 
Oxford Mindfulness Centre. The study will be conducted by Deirdre Noone and 
Jacob Payne. They work as Trainee Clinical Psychologists, and the study will form 
part of an educational qualification for both researchers (Doctorate in Clinical 
Psychology) at University College London (UCL). They are being supervised by Dr. 
Aimee Spector and Dr. Josh Stott, who are both Clinical Psychologists based at 
UCL. 
What is mindfulness training? 
Mindfulness is a way of training our attention to focus on the present moment, and 
to be kinder towards ourselves. Much of the time our minds are lost in thoughts 
about the past or the future. Living more in the ‘here and now’ may change our 
relationship with stress and worry. 
Research has shown mindfulness training to be helpful for many different kinds of 
people experiencing a range of difficulties, and there has been some limited research 
that suggests mindfulness may be beneficial for people with memory problems. 
Therefore, this study is designed to find out if people with memory problems 
attending mindfulness training experience improvements in their: mood, anxiety, 
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quality of life and thinking. 
We want to see if mindfulness training is better than usual care that people receive 
in services such as memory clinics and Improving Access to Psychological 
Therapies (IAPT) services. To do this, we will use a randomized controlled trial 
design, whereby half of the people that take part in the study will attend mindfulness 
sessions and half will receive usual care. The fairest way to decide whether or not 
people have the opportunity to attend the mindfulness sessions is by chance. The 
allocation will be done using an independent computer that will not contain any 
personal information about you. 
If you attend the mindfulness sessions you will be invited to attend an interview 
after the group. This will give you the opportunity to discuss your experience of 
attending the group. 
This study is a ‘pilot’. This means it is a small-scale study that will be used to 
prepare for a larger study. This pilot will help test out and improve the way future 
studies in this area are conducted. 
What happens in mindfulness training? 
Mindfulness training is a free eight-week course, and sessions take place once a 
week, lasting for about 60 minutes each time. The sessions will involve a group of 
about 5-10 people with low mood and memory problems. During the sessions you 
will do activities like: gentle breathing and learning to focus on your body. 
Why have I been invited to take part? 
You have been invited to take part because you are considered to be experiencing 
difficulties with your memory and mood. 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part, 
you will be given this information sheet to keep and be asked to sign a consent form. 
If you decide to take part, you are still free to withdraw at any time without giving a 
reason. A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you receive. 
What will happen to me if I take part? 
Following discussion of any questions you may have with a researcher, and signing 
the consent form, all participants will be asked to: 
Ø Meet with a researcher for around one hour to answer questions about 
your attention, mood, anxiety, quality of life and thinking. The time 
stated to complete the interviews and questionnaires is an estimate; you 
may take as many breaks as you want or feel necessary, and if you 
prefer we can meet for more sessions to finish these.  
Ø Either attend eight-weekly mindfulness training sessions OR receive 
your usual care for eight weeks.  
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Ø Meet with a researcher again to answer the same questions as before. In 
order to complete the assessment, the researcher may ask to meet a 
family member or your clinician to complete some questionnaires. The 
mindfulness training sessions will be audio recorded and will be kept 
password protected. 
Ø If you attend the eight-weekly mindfulness training sessions, you will 
be invited to attend an interview to discuss your experience of attending 
the group. 
What do I have to do? 
You can carry on your everyday activities as normal while participating in the study. 
All we ask is that if you are allocated to the mindfulness group, you try to attend all 
8 sessions. We understand there may be times when you are unwell and therefore 
unable to attend a session. 
What are the possible disadvantages and risks of taking part? 
We appreciate that when you are experiencing memory problems, it may be hard to 
talk about things like your mood and quality of life. The researcher carrying out the 
assessments and interviews is someone who has clinical experience and is working 
under supervision. 
You will be encouraged but never forced to take part in a particular activity during 
the sessions. Overall the risks of taking part in this study are minimal. However, if 
being involved in this research really does not suit you, for example if you find it 
distressing, you are free to withdraw at any point. 
What are the possible benefits of taking part? 
There are no proven benefits for the participants to take part in this study. Although 
we hope that attending the sessions is a helpful and enjoyable experience, we cannot 
promise this. Previous research into mindfulness suggests that people can experience 
greater awareness, acceptance, control, improved coping and enjoyment. If you 
decide to take part in the interview after the mindfulness training, we hope that you 
may find having the opportunity to talk about the group an interesting experience. 
For all participants, the information we get from this study may help us to support 
people with memory problems better in the future.  
Will my taking part in the study be kept confidential? 
We will ask for your permission to send your GP a letter explaining that you will be 
taking part in the study. All information collected about you over the course of the 
study will be kept private unless we became aware of something which made us 
worry about you or someone around you, in which case we will discuss the issue 
with you. For example, if we had some concern that you were at risk to yourself or 
other people, we may need to disclose this information with those involved in your 
care (e.g. your GP). All documents that leave the memory clinic will have your 
name removed with the exception of a consent form. The interviews will be 
recorded and transcribed. Any quotes from interviews that are used for publication 
will be anonymised. Once the study has finished, University College London will 
keep the study data in a secure location. The MBCT group sessions maybe recorded 
		 107	
for supervision purposes. This is to ensure that the facilitators are providing the 
optimum intervention. These recordings will be deleted after the facilitators have 
received feedback about the group. 
What will happen if I don’t want to carry on with the study? 
You will be free to withdraw from the study at any time, without giving a reason. 
Withdrawing from the study will not affect the standard of care you receive. We will 
need to use all data collected in the study, up to the point of withdrawal. 
What if something goes wrong? 
Every care will be taken in the course of this study. However, in the unlikely event 
that you are injured by taking part, compensation may be available. 
If you suspect that the injury is the result of the Sponsor’s (University College 
London) or the memory clinic's negligence then you may be able to claim 
compensation. After discussing with the researcher, please make the claim in writing 
to Dr. Aimee Spector who is the Chief Investigator for the research and is based at 
University College London. Her details are provided at the end of this form. The 
Chief Investigator will then pass the claim to the Sponsor’s Insurers, via the 
Sponsor’s office. You may have to bear the costs of the legal action initially, and 
you should consult a lawyer about this. 
Regardless of this, if you wish to make a complaint about any aspect of the way you 
have been approached or treated during the course of this study or if you are 
unhappy with anything about your participation, you can contact Dr Aimee Spector. 
If you have private medical insurance, you should inform your insurance company 
that you are intending to take part in this study. 
Is the research insured? 
The research study is covered by UCL policy which provides insurance for negligent 
harm. 
What will happen to the results of the research? 
The results will be published in health journals. No participants will be identified in 
any publication. Once the study has ended, you can meet with a researcher to find 
out about the results. The researchers will also present the study findings to people 
at your care home. 
Who has reviewed the study? 
All NHS research is looked at by a group of people, called a Research Ethics 
Committee to protect your safety, rights, and dignity. This study has been approved 
by X Research Ethics Committee. 
Who can I contact for further information? 
For more information about this research, please contact: 
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Deirdre Noone and Jacob Payne 
Department of Clinical,  
Educational and Health Psychology  
UCL Gower Street  
WC1E 6BT  
Email:  
 
Dr Aimee Spector  
Department of Clinical,  
Educational and Health Psychology  
UCL  
Gower Street  
WC1E 6BT  
Email:  
 
 
Dr Josh Stott  
Department of Clinical,  
Educational and Health Psychology  
UCL  
Gower Street  
WC1E 6BT  
 
If you would like seek advice from an independent person who is not associated 
with the project, please contact: 
Dr Will Mandy 
Senior Lecturer,  
Department of Clinical,  
Educational and Health Psychology  
UCL  
Gower Street  
WC1E 6BT  
Email:  
 
Or if you have any complaints about this study please contact: 
Dr Aimee Spector  
Department of Clinical,  
Educational and Health Psychology  
UCL  
Gower Street  
WC1E 6BT  
Email:  
 
 
Thank you for thinking about taking part in this research study.
Appendix D2: Participant Consent Form 
 
RESEARCH DEPARTMENT OF CLINICAL, EDUCATIONAL AND HEALTH 
PSYCHOLOGY 
 
 
Participant Consent Form 
Study Title: A Mindfulness-Based Cognitive Therapy (MBCT) Group for People 
with Memory Problems and Low Mood in Memory Clinic: A Feasibility Pilot Study 
(Student Research Project). 
Participant Number: 
Name of Researchers: Deirdre Noone and Jacob Payne 
Chief Investigator: Dr. Aimee Spector  
Academic Supervisors: Dr. Aimee Spector and Dr. Josh Stott 
 Please Initial Boxes 
I confirm that I have read and understand the information 
sheet dated [insert date, insert version] for the above study, 
have had the opportunity to ask questions and have had 
these answered acceptably. 
 
I understand that my participation is voluntary and that I 
am free to withdraw at any time, without giving any 
reason, without my medical care or legal rights being 
affected. 
 
I understand that sections of any of my medical notes and 
data collected during the study may be looked at by 
individuals involved in the study, where it is relevant to my 
taking part in this research. I give my permission for these 
individuals to have access to my records 
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I give permission for the MBCT sessions to be recorded for 
supervision purposes 
 
I give permission for my GP to be informed of my 
participation in the study 
 
I understand that all information given by me or about me 
will be treated as confidential by the research team. 
 
I agree to take part in the above study  
 
 
Name of participant 
 
 
 
 
 
 
 
Date Signature  
 
 
Name of person taking 
consent (if different 
from the principal 
researcher) 
 
 
 
 
 
Date Signature  
 
Principal researcher 
 
 
 
 
Date Signature  
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Appendix D3: Carer Information Sheet 
 
 
 
 
INFORMATION SHEET FOR CARER or FAMILY MEMBER  
Study Title: A Mindfulness-Based Cognitive Therapy (MBCT) Group for People 
with Memory Problems and Low Mood: A Feasibility Pilot Study (Student Research 
Project). 
Invitation to participate in a research study 
You are being invited to take part in a research study. Before you decide, it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Thank you for reading this information sheet. 
What is the purpose of the study? 
This study aims to find out whether mindfulness training can help improve the 
mood, anxiety and quality of life of people experiencing memory problems and low 
mood. 
What is mindfulness training? 
Mindfulness is a way of training our attention to focus on the present moment, and 
to be kinder towards ourselves. Much of the time our minds are lost in thoughts 
about the past or the future. Research has shown mindfulness training to be helpful 
for many different kinds of people experiencing a range of difficulties, including 
memory problems and low mood. Therefore, this study is designed to find out if 
people with memory problems and low mood attending mindfulness training will 
experience improvements in their: mood, anxiety, quality of life and thinking. 
We want to see if mindfulness training is better than usual care that people receive 
in either memory clinics or Improving Access to Psychological Therapies (IAPT) 
services . To do this, half of the people that take part in the study will attend 
mindfulness sessions and half will receive usual care. The fairest way to decide 
whether or not people have the opportunity to attend the mindfulness sessions is by 
chance. The allocation will be done using an independent computer that will not 
contain any personal information about you. 
RESEARCH DEPARTMENT OF CLINICAL, EDUCATIONAL AND HEALTH PSYCHOLOGY 
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If you know a participant that took part in mindfulness training you will be invited 
to attend an interview after the eight-week course. 
This study is a ‘pilot’. This means it is a small-scale study that will be used to 
prepare for a larger study. This pilot will help test out and improve the way future 
studies in this area are conducted. 
What happens in mindfulness training? 
Mindfulness training is a free eight-week course, and sessions take place once a 
week, lasting for about 60 minutes each time. The sessions will involve a group of 
about 5-10 people with low mood and memory problems. During the sessions 
participants will do activities like: gentle breathing and learning to focus on your 
body. 
Why have I been invited to take part? 
You have been invited to take part because you know a participant taking part in 
study, and therefore could assist the researchers in completing some assessments and 
answering some questions about the participant.
Appendix D4: Carer Consent Form 
 
 
 
Carer Consent Form 
 
Study Title: A Mindfulness-Based Cognitive Therapy (MBCT) Group for People 
with Memory Problems and Low Mood in Memory Clinic: A Feasibility Pilot Study 
(Student Research Project). 
Participant Number: 
Name of Researchers: Deirdre Noone and Jacob Payne 
Chief Investigator: Dr. Aimee Spector  
Academic Supervisors: Dr. Aimee Spector and Dr. Josh Stott      
                                                                                     
Please Initial Boxes 
 
 
 
I confirm that I have read and understand the information sheet dated [insert 
date, insert version] for the above study, have had the opportunity to ask 
questions and have had these answered acceptably. 
 
I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my medical care or legal rights 
being affected. 
 
I understand that all information given by me or about me will be treated as 
confidential by the research team. 
 
I agree to take part in the above study  
RESEARCH DEPARTMENT OF CLINICAL, EDUCATIONAL AND HEALTH PSYCHOLOGY 
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Name of participant 
 
 
 
Date Signature  
 
 
Name of person taking 
consent (if different 
from the principal 
researcher) 
 
 
Date Signature  
 
Principal researcher 
 
 
 
Date Signature  
 
 
 
 
 
 
 
 
 
 
 
 
	 115	
Appendix E: Ethical Approval 
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Appendix F: Local Research and Development Approval 
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Appendix G: Insurance 
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Appendix H: CONSORT Checklist 
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